<!--?xml version="1.0" encoding="utf-8"?--><!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd"><html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <!-- AppResources meta begin -->
        <script type="text/javascript">var ncbi_startTime = new Date();</script>
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="">

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="pmc"><meta name="ncbi_pdid" content="article"><meta name="ncbi_acc" content=""><meta name="ncbi_domain" content="plosone"><meta name="ncbi_report" content="record"><meta name="ncbi_type" content="fulltext"><meta name="ncbi_objectid" content=""><meta name="ncbi_pcid" content="/articles/PMC2951909/"><meta name="ncbi_app" content="pmc">
        <!-- Logger end -->
        
        <title>
1H-NMR-Based Metabolomic Profiling of CSF in Early Amyotrophic Lateral Sclerosis</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css"><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE"><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2951909/"><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/"><meta name="citation_journal_title" content="PLoS ONE"><meta name="citation_title" content="
1H-NMR-Based Metabolomic Profiling of CSF in Early Amyotrophic Lateral Sclerosis"><meta name="citation_authors" content="Hélène Blasco, Philippe Corcia, Caroline Moreau, Ségolène Veau, Clémentine Fournier, Patrick Vourc'h, Patrick Emond, Paul Gordon, Pierre-François Pradat, Julien Praline, David Devos, Lydie Nadal-Desbarats, Christian R. Andres"><meta name="citation_date" content="2010"><meta name="citation_issue" content="10"><meta name="citation_volume" content="5"><meta name="citation_doi" content="10.1371/journal.pone.0013223"><meta name="citation_abstract_html_url" content="/pmc/articles/PMC2951909/?report=abstract"><meta name="citation_pmid" content="20949041"><meta name="DC.Title" content="
1H-NMR-Based Metabolomic Profiling of CSF in Early Amyotrophic Lateral Sclerosis"><meta name="DC.Type" content="Text"><meta name="DC.Publisher" content="Public Library of Science"><meta name="DC.Contributor" content="Hélène Blasco"><meta name="DC.Contributor" content="Philippe Corcia"><meta name="DC.Contributor" content="Caroline Moreau"><meta name="DC.Contributor" content="Ségolène Veau"><meta name="DC.Contributor" content="Clémentine Fournier"><meta name="DC.Contributor" content="Patrick Vourc'h"><meta name="DC.Contributor" content="Patrick Emond"><meta name="DC.Contributor" content="Paul Gordon"><meta name="DC.Contributor" content="Pierre-François Pradat"><meta name="DC.Contributor" content="Julien Praline"><meta name="DC.Contributor" content="David Devos"><meta name="DC.Contributor" content="Lydie Nadal-Desbarats"><meta name="DC.Contributor" content="Christian R. Andres"><meta name="DC.Date" content="2010"><meta name="DC.Identifier" content="10.1371/journal.pone.0013223"><meta name="DC.Language" content="en"><meta property="og:title" content="
1H-NMR-Based Metabolomic Profiling of CSF in Early Amyotrophic Lateral Sclerosis"><meta property="og:type" content="article"><meta property="og:description" content="Pathophysiological mechanisms involved in amyotrophic lateral sclerosis (ALS) are complex and none has identified reliable markers useful in routine patient evaluation. The aim of this study was to analyze the CSF of patients with ALS by [1] H NMR (Nuclear ..."><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2951909/"><meta property="og:site_name" content="PubMed Central (PMC)"><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png"><meta name="twitter:card" content="summary"><meta name="twitter:site" content="@ncbi"><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc.min.css" type="text/css"><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc_extras_prnt.min.css" type="text/css" media="print"><script type="text/javascript" src="/corehtml/pmc/js/common.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:'https://api.ncbi.nlm.nih.gov/lit/ctxp/v1/pmc/'"><script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/jquery.citationexporter.min.js">//</script><link rel="stylesheet" href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/citationexporter.css" type="text/css"><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-plosone.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">
        div.pmc_para_cit li.highlight,
        div.pmc_para_cit li.highlight .one_line_source
        { background: #E0E0E0; }
        a.bibr.highlight { background: #E0E0E0; } 
      </style><meta name="cited_in_systematic_reviews" content=""><link rel="alternate" type="application/epub+zip" href="/pmc/articles/PMC2951909/epub/"><link rel="alternate" type="application/pdf" href="/pmc/articles/PMC2951909/pdf/pone.0013223.pdf">

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico"><meta name="ncbi_phid" content="8A1ADAEFE8E351910000000003290329.m_8">
<meta name="referrer" content="origin-when-cross-origin"><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css"><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print"><script async="1" src="https://www.google-analytics.com/analytics.js"></script><style type="text/css">.ncbi-alerts { background: none repeat scroll 0% 0% #671414;color: #fff;padding: .231em 1.231em;}.ncbi-alerts p { color: #fff; }.ncbi-alerts a, .ncbi-alerts a:visited {color: #fff; background: none;}.ncbi-alerts p {margin: 1em 0;padding: 0 0 0 1.5em; }.ncbi-alerts p:nth-child(1) {background-image: url('/core/icons/information.png');background-position: left top;background-repeat: no-repeat }.ncbi-alerts.subclosed p:nth-child(1) {background-image: url('/core/alerts/warning.png');}.ncbi-alerts.subclosed p { padding-left: 2em;}.ncbi-alerts.pubmed, .ncbi-alerts.pubmed p {background-color: #97B0C8; color: #000;}.ncbi-alerts a { text-decoration: underline !important; }.ncbi-alerts.pubmed a, .ncbi-alerts.pubmed a:visited { color: #000; }.ncbi-alerts, .ncbi-alerts p {background-color: #97B0C8; color: #000;}.ncbi-alerts a, .ncbi-alerts a:visited { color: #000; }</style></head>
    <body class="article" id="ui-ncbiexternallink-3">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	&lt;p class="nojs"&gt;
	&lt;strong&gt;Warning:&lt;/strong&gt;
	The NCBI web site requires JavaScript to function. 
	&lt;a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank"&gt;more...&lt;/a&gt;
	&lt;/p&gt;
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list ui-ncbibasicmenu orientation_hort" id="navcontent" role="menubar"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt" role="presentation"><a class="ui-ncbimenu-link-first" href="/" role="menuitem" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo"></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources" tabindex="-1" role="menuitem">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto" tabindex="-1" role="menuitem">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi" style="top: -0.4em;"><iframe src="https://eutils.ncbi.nlm.nih.gov/entrez/eutils/emyncbi.fcgi?cmd=htmlportal&amp;currenturl=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2951909%2F" style="border:none; height:2.5em; width:40em;" scrolling="no"></iframe></div></div>
                            <div class="header" style="margin-bottom: 0px;">
    <div class="res_logo">
  <h1 class="img_logo"><a href="/pmc/" class="pmc_logo offscreen">PMC</a></h1>
  <div class="NLMLogo">
    <a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>
    <br>
    <a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>
  </div>
</div>
    <div class="search"><form method="get" action="/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" class="last" data-ac_dict="pmc-search-autocomplete">PMC</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><div class="jig-ncbiclearbutton-wrap ui-ncbiclearbutton-wrap box-shadow"><input type="text" name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'pmc-search-autocomplete',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'yes'" aria-haspopup="true" aria-autocomplete="list" role="textbox"><a class="reset" href="#" style="visibility: hidden;"><img src="/core/jig/1.14.8/img/clear.png" alt="Clear input"></a></div></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/pmc/advanced/">Advanced</a>
                    </li><li>
                        <a href="/pmc/journals/">Journal list</a>
                    </li><li class="help">
                        <a target="_blank" href="/books/NBK3825/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <div class="container">
    <div id="maincontent" class="content eight_col col">
        <div class="navlink-box">
            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="/pmc/journals/" class="navlink">Journal List</a></li><li class="archive"><a class="navlink" href="/pmc/journals/440/">PLoS One</a></li><li class="issue-page"><a class="navlink" href="/pmc/issues/190416/">v.5(10); 2010</a></li><li class="accid">PMC2951909</li></ul>
        </div>

        <!-- Journal banner -->
        <div class="pmc-page-banner whole_rhythm"><div><img src="/corehtml/pmc/pmcgifs/logo-plosone.gif" alt="Logo of plosone" usemap="#logo-imagemap"><map id="logo-imagemap" name="logo-imagemap"><area shape="rect" coords="0,0,438,55" alt="PLoS One" title="PLoS One" href="http://www.plosone.org/" ref="reftype=publisher&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"><area shape="rect" coords="0,56,104,74" alt="View this Article" title="View this Article" href="//dx.doi.org/10.1371/journal.pone.0013223" ref="reftype=publisher&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article%7CBanner&amp;TO=Content%20Provider%7CArticle%7CFullText" target="pmc_ext"><area shape="rect" coords="106,56,202,74" alt="Submit to PLoS" title="Submit to PLoS" href="http://www.plosone.org/static/checklist.action" ref="reftype=publisher&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"><area shape="rect" coords="204,56,302,74" alt="Get E-mail Alerts" title="Get E-mail Alerts" href="http://journals.plos.org/alerts" ref="reftype=publisher&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"><area shape="rect" coords="304,56,374,74" alt="Contact Us" title="Contact Us" href="http://www.plosone.org/static/contact.action" ref="reftype=publisher&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"><area shape="rect" coords="440,0,500,55" alt="Public Library of Science (PLoS)" title="Public Library of Science (PLoS)" href="http://www.plos.org/" ref="reftype=publisher&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"></map></div> </div>
        
        <!--component id='MainPortlet' label='search-reference'/-->
        
        <!-- Book content -->
        <div class="">
            
        
            
            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden'" id="ui-ncbiinpagenav-1"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="inline_block eight_col va_top"><div><div><span class="cit"><span role="menubar"><a href="#" role="menuitem" aria-expanded="false" aria-haspopup="true">PLoS One</a></span>. 2010; 5(10): e13223. </span></div><div><span class="fm-vol-iss-date">Published online 2010 Oct 8. </span>  <span class="doi">doi:&nbsp;<a href="//dx.doi.org/10.1371%2Fjournal.pone.0013223" target="pmc_ext" ref="reftype=other&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1371/journal.pone.0013223</a></span></div></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC2951909</span></div><div class="fm-citation-pmid">PMID: <a href="/pubmed/20949041">20949041</a></div></div></div></div><h1 class="content-title">
<sup>1</sup>H-NMR-Based Metabolomic Profiling of CSF in Early Amyotrophic Lateral Sclerosis</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="/pubmed/?term=Blasco%20H%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20949041" class="affpopup" co-rid="_co_idm139768749918432" co-class="co-affbox">Hélène Blasco</a>,<sup>
1
,</sup><sup>
2
,</sup><sup>
3
,</sup><sup>
*
</sup> <a href="/pubmed/?term=Corcia%20P%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20949041" class="affpopup" co-rid="_co_idm139768830793392" co-class="co-affbox">Philippe Corcia</a>,<sup>
1
,</sup><sup>
2
,</sup><sup>
4
</sup> <a href="/pubmed/?term=Moreau%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20949041" class="affpopup" co-rid="_co_idm139768830788784" co-class="co-affbox">Caroline Moreau</a>,<sup>
5
</sup> <a href="/pubmed/?term=Veau%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20949041" class="affpopup" co-rid="_co_idm139768830786416" co-class="co-affbox">Ségolène Veau</a>,<sup>
3
</sup> <a href="/pubmed/?term=Fournier%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20949041" class="affpopup" co-rid="_co_idm139768757114032" co-class="co-affbox">Clémentine Fournier</a>,<sup>
3
</sup> <a href="/pubmed/?term=Vourc'h%20P%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20949041" class="affpopup" co-rid="_co_idm139768757111664" co-class="co-affbox">Patrick Vourc'h</a>,<sup>
1
,</sup><sup>
2
,</sup><sup>
3
,</sup><sup>
6
</sup> <a href="/pubmed/?term=Emond%20P%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20949041" class="affpopup" co-rid="_co_idm139768757105936" co-class="co-affbox">Patrick Emond</a>,<sup>
1
,</sup><sup>
2
,</sup><sup>
3
,</sup><sup>
6
</sup> <a href="/pubmed/?term=Gordon%20P%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20949041" class="affpopup" co-rid="_co_idm139768753328256" co-class="co-affbox">Paul Gordon</a>,<sup>
7
</sup> <a href="/pubmed/?term=Pradat%20PF%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20949041" class="affpopup" co-rid="_co_idm139768753325888" co-class="co-affbox">Pierre-François Pradat</a>,<sup>
8
</sup> <a href="/pubmed/?term=Praline%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20949041" class="affpopup" co-rid="_co_idm139768753323520" co-class="co-affbox">Julien Praline</a>,<sup>
1
,</sup><sup>
2
,</sup><sup>
4
</sup> <a href="/pubmed/?term=Devos%20D%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20949041" class="affpopup" co-rid="_co_idm139768752769968" co-class="co-affbox">David Devos</a>,<sup>
5
</sup> <a href="/pubmed/?term=Nadal-Desbarats%20L%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20949041" class="affpopup" co-rid="_co_idm139768752767600" co-class="co-affbox">Lydie Nadal-Desbarats</a>,<sup>
1
,</sup><sup>
2
,</sup><sup>
6
</sup> and  <a href="/pubmed/?term=Andres%20CR%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20949041" class="affpopup" co-rid="_co_idm139768755913632" co-class="co-affbox">Christian R. Andres</a><sup>
1
,</sup><sup>
2
,</sup><sup>
3
</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm139768749918432"><h3 class="no_margin">Hélène Blasco</h3><p>  <sup>1</sup>  Inserm U930, CNRS 2448, Tours, France,   </p><p>  <sup>2</sup>  Université François-Rabelais, Tours, France,   </p><p>  <sup>3</sup>  CHRU de Tours, Laboratoire de Biochimie et Biologie Moléculaire, Tours, France,   </p><div>Find articles by <a href="/pubmed/?term=Blasco%20H%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20949041">Hélène Blasco</a></div></div><div id="_co_idm139768830793392"><h3 class="no_margin">Philippe Corcia</h3><p>  <sup>1</sup>  Inserm U930, CNRS 2448, Tours, France,   </p><p>  <sup>2</sup>  Université François-Rabelais, Tours, France,   </p><p>  <sup>4</sup>  CHRU de Tours, Service de Neurologie, Tours, France,   </p><div>Find articles by <a href="/pubmed/?term=Corcia%20P%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20949041">Philippe Corcia</a></div></div><div id="_co_idm139768830788784"><h3 class="no_margin">Caroline Moreau</h3><p>  <sup>5</sup>  CHRU de Lille, Service de Neurologie, Lille, France,   </p><div>Find articles by <a href="/pubmed/?term=Moreau%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20949041">Caroline Moreau</a></div></div><div id="_co_idm139768830786416"><h3 class="no_margin">Ségolène Veau</h3><p>  <sup>3</sup>  CHRU de Tours, Laboratoire de Biochimie et Biologie Moléculaire, Tours, France,   </p><div>Find articles by <a href="/pubmed/?term=Veau%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20949041">Ségolène Veau</a></div></div><div id="_co_idm139768757114032"><h3 class="no_margin">Clémentine Fournier</h3><p>  <sup>3</sup>  CHRU de Tours, Laboratoire de Biochimie et Biologie Moléculaire, Tours, France,   </p><div>Find articles by <a href="/pubmed/?term=Fournier%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20949041">Clémentine Fournier</a></div></div><div id="_co_idm139768757111664"><h3 class="no_margin">Patrick Vourc'h</h3><p>  <sup>1</sup>  Inserm U930, CNRS 2448, Tours, France,   </p><p>  <sup>2</sup>  Université François-Rabelais, Tours, France,   </p><p>  <sup>3</sup>  CHRU de Tours, Laboratoire de Biochimie et Biologie Moléculaire, Tours, France,   </p><p>  <sup>6</sup>  Laboratoire de RMN - PPF “Analyses des Systèmes Biologiques”, Université François-Rabelais, Tours, France,   </p><div>Find articles by <a href="/pubmed/?term=Vourc'h%20P%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20949041">Patrick Vourc'h</a></div></div><div id="_co_idm139768757105936"><h3 class="no_margin">Patrick Emond</h3><p>  <sup>1</sup>  Inserm U930, CNRS 2448, Tours, France,   </p><p>  <sup>2</sup>  Université François-Rabelais, Tours, France,   </p><p>  <sup>3</sup>  CHRU de Tours, Laboratoire de Biochimie et Biologie Moléculaire, Tours, France,   </p><p>  <sup>6</sup>  Laboratoire de RMN - PPF “Analyses des Systèmes Biologiques”, Université François-Rabelais, Tours, France,   </p><div>Find articles by <a href="/pubmed/?term=Emond%20P%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20949041">Patrick Emond</a></div></div><div id="_co_idm139768753328256"><h3 class="no_margin">Paul Gordon</h3><p>  <sup>7</sup>  Northern Navajo Medical Center, Shiprock, New Mexico, United States of America,   </p><div>Find articles by <a href="/pubmed/?term=Gordon%20P%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20949041">Paul Gordon</a></div></div><div id="_co_idm139768753325888"><h3 class="no_margin">Pierre-François Pradat</h3><p>  <sup>8</sup>  APHP, Fédération des Maladies du Système Nerveux, Centre Référent Maladie Rare SLA, Hôpital de la Pitié-Salpétriere, Paris, France,   </p><div>Find articles by <a href="/pubmed/?term=Pradat%20PF%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20949041">Pierre-François Pradat</a></div></div><div id="_co_idm139768753323520"><h3 class="no_margin">Julien Praline</h3><p>  <sup>1</sup>  Inserm U930, CNRS 2448, Tours, France,   </p><p>  <sup>2</sup>  Université François-Rabelais, Tours, France,   </p><p>  <sup>4</sup>  CHRU de Tours, Service de Neurologie, Tours, France,   </p><div>Find articles by <a href="/pubmed/?term=Praline%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20949041">Julien Praline</a></div></div><div id="_co_idm139768752769968"><h3 class="no_margin">David Devos</h3><p>  <sup>5</sup>  CHRU de Lille, Service de Neurologie, Lille, France,   </p><div>Find articles by <a href="/pubmed/?term=Devos%20D%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20949041">David Devos</a></div></div><div id="_co_idm139768752767600"><h3 class="no_margin">Lydie Nadal-Desbarats</h3><p>  <sup>1</sup>  Inserm U930, CNRS 2448, Tours, France,   </p><p>  <sup>2</sup>  Université François-Rabelais, Tours, France,   </p><p>  <sup>6</sup>  Laboratoire de RMN - PPF “Analyses des Systèmes Biologiques”, Université François-Rabelais, Tours, France,   </p><div>Find articles by <a href="/pubmed/?term=Nadal-Desbarats%20L%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20949041">Lydie Nadal-Desbarats</a></div></div><div id="_co_idm139768755913632"><h3 class="no_margin">Christian R. Andres</h3><p>  <sup>1</sup>  Inserm U930, CNRS 2448, Tours, France,   </p><p>  <sup>2</sup>  Université François-Rabelais, Tours, France,   </p><p>  <sup>3</sup>  CHRU de Tours, Laboratoire de Biochimie et Biologie Moléculaire, Tours, France,   </p><div>Find articles by <a href="/pubmed/?term=Andres%20CR%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20949041">Christian R. Andres</a></div></div></div></div><div class="contrib-group half_rhythm fm-editor">Vladimir N. Uversky, <span class="fm-role">Editor</span><sup></sup></div><div class="fm-panel half_rhythm"><div class="togglers"><a href="#" class="pmctoggle" rid="idm139768738974272_ai idm139768749918560_ai idm139768748289936_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm139768738974272_an">Article notes</a> <a href="#" class="pmctoggle" rid="idm139768738974272_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-authors-info fm-panel hide half_rhythm" id="idm139768738974272_ai" style="display:none"><div class="fm-affl" lang="en" id="aff1">  <sup>1</sup>  Inserm U930, CNRS 2448, Tours, France,   </div><div class="fm-affl" lang="en" id="aff2">  <sup>2</sup>  Université François-Rabelais, Tours, France,   </div><div class="fm-affl" lang="en" id="aff3">  <sup>3</sup>  CHRU de Tours, Laboratoire de Biochimie et Biologie Moléculaire, Tours, France,   </div><div class="fm-affl" lang="en" id="aff4">  <sup>4</sup>  CHRU de Tours, Service de Neurologie, Tours, France,   </div><div class="fm-affl" lang="en" id="aff5">  <sup>5</sup>  CHRU de Lille, Service de Neurologie, Lille, France,   </div><div class="fm-affl" lang="en" id="aff6">  <sup>6</sup>  Laboratoire de RMN - PPF “Analyses des Systèmes Biologiques”, Université François-Rabelais, Tours, France,   </div><div class="fm-affl" lang="en" id="aff7">  <sup>7</sup>  Northern Navajo Medical Center, Shiprock, New Mexico, United States of America,   </div><div class="fm-affl" lang="en" id="aff8">  <sup>8</sup>  APHP, Fédération des Maladies du Système Nerveux, Centre Référent Maladie Rare SLA, Hôpital de la Pitié-Salpétriere, Paris, France,   </div><div class="fm-affl" lang="en" id="edit1">Indiana University, United States of America</div><div id="cor1">* E-mail: <a href="mailto:dev@null" data-email="rf.sruot-vinu@ocsalb.eneleh" class="oemail">rf.sruot-vinu@ocsalb.eneleh</a></div><div><p id="__p1" class="p p-first-last">Conceived and designed the experiments: PC PV PHG JP CRA. Performed the experiments: HB SV CF LND. Analyzed the data: HB PE LND. Contributed reagents/materials/analysis tools: PC CM PFP JP DD CRA. Wrote the paper: HB PHG LND.</p></div></div><div class="fm-article-notes fm-panel hide half_rhythm" id="idm139768738974272_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2010 Jun 18; Accepted 2010 Sep 8.</div></div><div class="permissions fm-panel half_rhythm hide" id="idm139768738974272_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a> Blasco et al.</div><div class="license half_rhythm">This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.</div></div></div><div id="pmclinksbox" class="links-box whole_rhythm"><div class="fm-panel"><div><strong>This article has been corrected. </strong>See <a href="/pmc/articles/PMC2982987/">PLoS One. 2010; 5(11): 10.1371/annotation/2c2f8fce-a5be-40a3-af8f-48f119b2c593</a>.</div><div style="border-top: 1px solid rgb(102, 102, 153); margin: 5px 10% 3px;"></div><div>This article has been <a href="/pmc/articles/PMC2951909/citedby/">cited by</a> other articles in PMC.</div></div></div></div><div class="sec"></div><div id="idm139768753978592" lang="en" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><span role="menubar"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="menuitem" aria-expanded="false" aria-haspopup="true">Go to:</a></span></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm139768753978592title">Abstract</h2><!--article-meta--><div><div id="__sec1" class="sec sec-first"><h3 id="__sec1title">Background</h3><p id="__p2" class="p p-first-last">Pathophysiological mechanisms involved in amyotrophic lateral sclerosis (ALS) are complex and none has identified reliable markers useful in routine patient evaluation. The aim of this study was to analyze the CSF of patients with ALS by <sup>1</sup>H NMR (Nuclear Magnetic Resonance) spectroscopy in order to identify biomarkers in the early stages of the disease, and to evaluate the biochemical factors involved in ALS.</p></div><div id="__sec2" class="sec"><h3 id="__sec2title">Methodology</h3><p id="__p3" class="p p-first-last">CSF samples were collected from patients with ALS at the time of diagnosis and from patients without neurodegenerative diseases. One and two-dimensional <sup>1</sup>H NMR analyses were performed and metabolites were quantified by the ERETIC method. We compared the concentrations of CSF metabolites between both groups. Finally, we performed principal component (PCA) and discriminant analyses.</p></div><div id="__sec3" class="sec"><h3 id="__sec3title">Principal Findings</h3><p id="__p4" class="p p-first-last">Fifty CSF samples from ALS patients and 44 from controls were analyzed. We quantified 17 metabolites including amino-acids, organic acids, and ketone bodies. Quantitative analysis revealed significantly lower acetate concentrations (p = 0.0002) in ALS patients compared to controls. Concentration of acetone trended higher (p = 0.015), and those of pyruvate (p = 0.002) and ascorbate (p = 0.003) were higher in the ALS group. PCA demonstrated that the pattern of analyzed metabolites discriminated between groups. Discriminant analysis using an algorithm of 17 metabolites revealed that patients were accurately classified 81.6% of the time.</p></div><div id="__sec4" class="sec sec-last"><h3 id="__sec4title">Conclusion/Significance</h3><p id="__p5" class="p p-first-last">CSF screening by NMR spectroscopy could be a useful, simple and low cost tool to improve the early diagnosis of ALS. The results indicate a perturbation of glucose metabolism, and the need to further explore cerebral energetic metabolism.</p></div></div></div><div id="s1" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="s1title">Introduction</h2><p id="__p6" class="p p-first">Amyotrophic lateral sclerosis (ALS), the most common adult-onset motor neuron disease, is characterized by degeneration of both lower and upper motor neurons leading to death within 2–5 years of onset <a href="#pone.0013223-Tandan1" rid="pone.0013223-Tandan1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_671900704" role="button" aria-expanded="false" aria-haspopup="true">[1]</a>. Although the underlying causes of motor neuron degeneration are still unknown, hypotheses suggest a role for oxidative stress, mitochondrial dysfunction, glutamate-mediated excitotoxicity, cytoskeletal abnormalities, and protein aggregation <a href="#pone.0013223-Shaw1" rid="pone.0013223-Shaw1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_671900692" role="button" aria-expanded="false" aria-haspopup="true">[2]</a>.</p><p id="__p7">The lack of biological tools to diagnose ALS together with the non specificity and heterogeneity of clinical symptoms lead difficulty in making the diagnosis in very early stages. Indeed, the time between the appearance of first symptoms and the diagnosis is often 9 months or more <a href="#pone.0013223-Kraemer1" rid="pone.0013223-Kraemer1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_671900723" role="button" aria-expanded="false" aria-haspopup="true">[3]</a>. Several authors have studied the potential use of blood and cerebrospinal fluid (CSF) biomarkers associated with ALS but these studies were limited to small numbers of target molecules supposed to be linked to ALS pathogenesis <a href="#pone.0013223-Mitchell1" rid="pone.0013223-Mitchell1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_671900719" role="button" aria-expanded="false" aria-haspopup="true">[4]</a>, <a href="#pone.0013223-Sussmuth1" rid="pone.0013223-Sussmuth1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_671900695" role="button" aria-expanded="false" aria-haspopup="true">[5]</a>, <a href="#pone.0013223-Tumani1" rid="pone.0013223-Tumani1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_671900701" role="button" aria-expanded="false" aria-haspopup="true">[6]</a>. While many <em>in vivo</em> studies have provided clues to pathogenesis mechanisms, none has identified reliable markers useful in routine patient evaluation. Recently, high-throughput techniques such as metabolomics have been used to evaluate a combination of markers in patients with neurological diseases <a href="#pone.0013223-Quinones1" rid="pone.0013223-Quinones1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_671900718" role="button" aria-expanded="false" aria-haspopup="true">[7]</a>. Metabolomic studies have been performed via different analytical methods such as high performance liquid chromatography followed by electrochemical detection <a href="#pone.0013223-Rozen1" rid="pone.0013223-Rozen1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_671900717" role="button" aria-expanded="false" aria-haspopup="true">[8]</a> or high resolution <sup>1</sup>H NMR (Nuclear Magnetic Resonance) spectroscopy <a href="#pone.0013223-Kumar1" rid="pone.0013223-Kumar1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_675008750" role="button" aria-expanded="false" aria-haspopup="true">[9]</a>. NMR spectroscopy appears to be cost-effective, useful in routine care, and screening <a href="#pone.0013223-AlaKorpela1" rid="pone.0013223-AlaKorpela1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_671900705" role="button" aria-expanded="false" aria-haspopup="true">[10]</a>. Different kinds of biological fluids have been screened <a href="#pone.0013223-Pradat1" rid="pone.0013223-Pradat1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_671900706" role="button" aria-expanded="false" aria-haspopup="true">[11]</a>, but CSF may have the highest yield of biomarkers in ALS because of its direct contact with the brain, its accessibility, and its dynamic changes with the cerebral environment.</p><p id="__p8" class="p p-last">The aim of this study was to search for a metabolic signature of ALS in the CSF using high resolution NMR spectroscopy. We compared <sup>1</sup>H NMR spectra of CSF samples collected from ALS patients and from patients without a neurodegenerative disease.</p></div><div id="s2" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="s2title">Methods</h2><div id="s2a" class="sec sec-first"><h3 id="s2atitle">Patients and controls</h3><p id="__p9" class="p p-first">Cerebrospinal fluid samples were obtained at the time of diagnosis from patients in three French ALS centers (Tours, Lille and Paris). The diagnosis of ALS was made according to diagnostic criteria for definite or probable ALS based on the El Escorial World Federation diagnostic criteria <a href="#pone.0013223-Brooks1" rid="pone.0013223-Brooks1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_671900716" role="button" aria-expanded="false" aria-haspopup="true">[12]</a>. In routine practice, a CSF analysis is performed in all patients in whom a diagnosis of ALS is suspected. All patients involved in our study gave informed consent. Patients from Lille and Paris gave written consent to perform research with their CSF samples. In routine practice, a CSF analysis is performed in all patients in whom a diagnosis of ALS is suspected. For our study, we used a part of CSF sample to perform complementary analysis with NMR. In Tours, before starting this study, we asked our local ethics committee about the requirement of informed consent. We obtained verbal permission from the Persons Protection Committee's President of Tours to use CSF samples obtained by routine check up and without written consent of patients and controls. Patients from Tours gave verbal consent to use their CSF samples for medical research. One of the clinicians was responsible to give to patients the appropriate information about the use of their CSF samples in medical research. Ethics committees approved consent procedure.</p><p id="__p10" class="p p-last">For each patient, information on diagnosis, gender, age, site-of-onset and age-at-onset were obtained. The site-of-onset was defined as either bulbar or limb-onset. The age-at-onset was defined as the time at which motor weakness was first noted by the patient. We compared clinical, demographic data and biological parameters of ALS patients between each center. According to ethical considerations, it is not conceivable to collect CSF from healthy subjects. Then, the control group encompassed individuals with non-neurodegenerative diseases having a routine lumbar puncture at the time of diagnosis. Standard clinical laboratory tests including bacteriological, biochemical analyses of CSF and blood glucose levels were collected for each subject.</p></div><div id="s2b" class="sec"><h3 id="s2btitle">Sample preparation</h3><p id="__p11" class="p p-first-last">CSF samples were stored in polypropylene tubes at −80°C immediately after collection and until analysis <a href="#pone.0013223-Wuolikainen1" rid="pone.0013223-Wuolikainen1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_671900722" role="button" aria-expanded="false" aria-haspopup="true">[13]</a>. Before the NMR experiments, samples were thawed, and centrifugated at 3000g for 5 minutes. Then 0.5 mL of CSF were mixed with 0.1 mL of deuterium oxyde solution to calibrate the NMR spectrometer. Final adjustment of pH to 9.5±0.15 was done with HCl or NaOH solutions using a pH-meter equipped with a glass combination electrode. Finally, 0.6 mL of the prepared solutions were transferred to a 5-mm NMR tube (CortecNet, Paris, France) for <sup>1</sup>H NMR analysis.</p></div><div id="s2c" class="sec"><h3 id="s2ctitle">Magnetic Resonance Spectroscopy experiments</h3><p id="__p12" class="p p-first">The <sup>1</sup>H NMR spectra were performed on a Bruker DRX-500 spectrometer (Bruker SADIS, Wissembourg, France), operating at 11.7 T, with a Broad Band Inverse (BBI) probehead equipped with Z gradient coil. NMR measurements were done at 298K, with non-spinning samples. CPMG <sup>1</sup>H NMR spectra were recorded with a spin-spin relaxation delay of 80ms (echo time 200 µs repeated 200 times), collected with 128 transients, eight dummy scans and a d1 of 10s into 32k data points with a spectral width of 7500 Hz and an acquisition time of 2.04s. The water peak was irradiated during d1 delay. Unambiguous assignments were performed using a two-dimensional correlation spectroscopy. Eight transients per increment and 256 increments were collected into 4K data points. COSY spectra were acquired with 3s relaxation delay, 6000Hz spectral width in both directions. The water signal was irradiated during the recycling time. Shimming of the sample was performed automatically on the water signal. For quantification of metabolite peaks, the electronic reference (ERETIC) signal was set during acquisition time <a href="#pone.0013223-Barantin1" rid="pone.0013223-Barantin1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_671900707" role="button" aria-expanded="false" aria-haspopup="true">[14]</a>. The ERETIC pulse was generated by a second radio frequency channel phase-synchronized with the NMR signal of the sample. ERETIC intensity, frequency and line broadening were calibrated with a reference tube to determine metabolite concentrations.</p><p id="__p13">Data were processed using XWinNMR version 3.5 software (Bruker Daltonik, Karlsruhe, Germany). Prior to Fourier transformation (FT), the 1D FIDs were zero-filled to 64K data points which provided sufficient data points for each resonance, and a line broadening factor of 0.3Hz was applied. All spectra were corrected for phase distortion and the baseline was manually corrected for each spectrum. Each spectrum was integrated using WinNMR software integral function.</p><p id="__p14">Quantification of metabolite peaks was performed with the ERETIC peak as a quantitative reference. Calibration of the ERETIC peak, which had the same area in all spectra, was made using a mixture of 9.13mM of citrate, 9.20mM of lactate, and 9.10mM of glutamate as the reference tube. According to this reference tube, the measured area of the ERETIC peak (A<sub>E</sub>) symbolized a calculated concentration (C<sub>E</sub>) of 4,67mM. Metabolite concentration (C<sub>X</sub>) was calculated according to the following formula:</p><div class="disp-formula"><div class="f"><img src="/pmc/articles/PMC2951909/bin/pone.0013223.e001.jpg" class="eq-image" alt="equation image" title="equation image"></div></div><p>where Cx is the metabolite concentration in the CSF sample, Nx is the number of protons of the quantified peak metabolite, C<sub>E</sub> is the calculated concentration for the ERETIC peak, A<sub>E</sub> is the ERETIC area peak, and f<sub>D</sub> is the dilution factor of the CSF sample.</p><p id="__p15" class="p p-last">Spectral <sup>1</sup>H assignments were achieved according to the literature values of chemical shifts in various media and biofluids <a href="#pone.0013223-Maillet1" rid="pone.0013223-Maillet1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_671900724" role="button" aria-expanded="false" aria-haspopup="true">[15]</a>. Because beta-methyl-L-amino-alanine (BMAA) has been recently reported by several authors as potentially involved in the etiology of ALS, we searched for its presence <a href="#pone.0013223-Spencer1" rid="pone.0013223-Spencer1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_675008747" role="button" aria-expanded="false" aria-haspopup="true">[16]</a>.</p></div><div id="s2d" class="sec sec-last"><h3 id="s2dtitle">Statistical analysis</h3><div id="s2d1" class="sec sec-first"><p></p><h4 id="s2d1title" class="inline">Univariate data analysis </h4><p id="__p16" class="p p-first">A comparison of CSF concentrations between ALS and non ALS patients was done to highlight the potential disturbances in the metabolic pathway due to ALS.</p><p id="__p17">We compared concentrations of CSF metabolites between ALS and non ALS patients using t-tests or Wilcoxon tests. Among the 53 metabolites identifiable in CSF by NMR <a href="#pone.0013223-Wishart1" rid="pone.0013223-Wishart1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_675008751" role="button" aria-expanded="false" aria-haspopup="true">[17]</a>, we quantified (by XWin NMR software) those having the highest signal, i.e quantifiable with the highest accuracy.</p><p id="__p18">A correction for multiple tests was applied to adjust the p values by accounting for the 17 metabolites evaluated in the analysis. Differences were considered as significant when p&lt;0.003.</p><p id="__p19" class="p p-last">Statistical analysis was performed with JMP statistical software version 7.0.2 (SAS Institute, Cary, North Carolina).</p></div><div id="s2d2" class="sec sec-last"><p></p><h4 id="s2d2title" class="inline">Multivariate data analysis </h4><p id="__p20" class="p p-first">Principal component analysis (PCA) was performed using SPAD<sup>©</sup> software (SPAD v5.6 software decisia, France). PCA is a descriptive multivariate analysis that rapidly identifies groups of samples according to their scores in different variables (i.e. different metabolites). Spectral variation is reduced to a series of principal components (PC), each representing correlated spectral changes and summarized in a score plot. PCs are new variables that are orthogonal to each other and explain progressively less variance in the data set. PCs were displayed in a two- dimensional score plot, allowing visualization of the distribution and grouping of the samples in the new variable space.</p><p id="__p21">Discriminating analysis was performed to evaluate how closely a set of measurement metabolites predict the classification of ALS and non ALS patients. Thus, we randomly divided our data into a training set of size 50 and a test set that consisted of the remaining patients. The model was built based on the training set with known clinical status to construct a set of linear functions of the measured metabolites. The clinical status was predicted from the test group to evaluate the power of prediction.</p><p id="__p22" class="p p-last">Statistical analysis was performed with JMP statistical software version 7.0.2 (SAS Institute, Cary, North Carolina) and R version 2.8.0, an open source program developed by the R Foundation for Statistical Computing (Vienna, Austria).</p></div></div></div><div id="s3" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="s3title">Results</h2><div id="s3a" class="sec sec-first"><h3 id="s3atitle">Patients and controls</h3><p id="__p23" class="p p-first">Clinical data and CSF samples were obtained from 50 patients with ALS (22 from Tours, 19 from Lille and 9 from Paris) and 44 controls. No differences in clinical, demographic or biological data were found between patients from Tours, Lille and Paris, so we pooled these samples into a single group: the ALS group. 61% of ALS patients were male and had median age-at-onset of 62.5 years (22.9–90.6). 65% of ALS patients had limb-onset. The control group encompassed patients with the following diseases : sarcoidosis (one patient), psychiatric disorders (three patients), cerebellar syndrome (one patient), peripheral neuropathy (thirteen patients), chronic inflammatory demyelinating polyneuropathy (six patients), muscular cramps (one patient), facial paralysis (one patient), traumatic cerebral injury (one patient), ataxia with axonal neuropathy (one patient), normal pressure hydrocephalus (two patients), paresthesia (two patients), epileptic seizures (one patient), spinal cord infarction (one patient), cervical spondylotic myelopathy (three patients), adrenomyeloneuropathy (one patient), non-organic hypoesthesia (one patient), neuroborreliosis (one patient), dystonia (one patient), Hallervorden-Spatz syndrome (one patient), non neurologic deafness (one patient), and oculomotor paralysis (one patient). Controls were matched with ALS patients by age and sex. There were no differences in standard bacteriological and biochemical tests of CSF, or in blood glucose levels between groups (<a href="/pmc/articles/PMC2951909/table/pone-0013223-t001/" target="table" class="fig-table-link figpopup" rid-figpopup="pone-0013223-t001" rid-ob="ob-pone-0013223-t001" co-legend-rid=""><span>
<strong>Table 1</strong>
</span></a>).</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="pone-0013223-t001"><h3>Table 1</h3><!--caption a7--><div class="caption"><!--caption a8--><strong>ALS and non ALS patients characteristics.</strong></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139768737210432" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">ALS patients (n = 50)</td><td align="left" rowspan="1" colspan="1">non ALS patients (n = 44)</td><td align="left" rowspan="1" colspan="1">p</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">
<strong>Sex</strong>
</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">Male</td><td align="left" rowspan="1" colspan="1">31 (62%)</td><td align="left" rowspan="1" colspan="1">27 (61%)</td><td align="left" rowspan="1" colspan="1">1.00</td></tr><tr><td align="left" rowspan="1" colspan="1">Female</td><td align="left" rowspan="1" colspan="1">19 (38%)</td><td align="left" rowspan="1" colspan="1">17 (39%)</td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">
<strong>Age</strong>
</td><td align="left" rowspan="1" colspan="1">64.6 (35.0–90.6)</td><td align="left" rowspan="1" colspan="1">60.6 (26.8–82.9)</td><td align="left" rowspan="1" colspan="1">0.20</td></tr><tr><td align="left" rowspan="1" colspan="1">
<strong>Blood</strong>
</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">Glucose (mmol/L)</td><td align="left" rowspan="1" colspan="1">5.3 (4.4–7.0)</td><td align="left" rowspan="1" colspan="1">5.9 (4.8–9.0)</td><td align="left" rowspan="1" colspan="1">0.11</td></tr><tr><td align="left" rowspan="1" colspan="1">
<strong>LCR</strong>
</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">Leucocytes/mm<sup>3</sup>
</td><td align="left" rowspan="1" colspan="1">1 (0–50)</td><td align="left" rowspan="1" colspan="1">1 (0–75)</td><td align="left" rowspan="1" colspan="1">0.32</td></tr><tr><td align="left" rowspan="1" colspan="1">Cell/mm<sup>3</sup>
</td><td align="left" rowspan="1" colspan="1">0 (0–2200)</td><td align="left" rowspan="1" colspan="1">1 (0–75)</td><td align="left" rowspan="1" colspan="1">0.80</td></tr><tr><td align="left" rowspan="1" colspan="1">Protein (g/L)</td><td align="left" rowspan="1" colspan="1">0.43 (0.33–1.08)</td><td align="left" rowspan="1" colspan="1">0.45 (0.24–6.23)</td><td align="left" rowspan="1" colspan="1">0.89</td></tr><tr><td align="left" rowspan="1" colspan="1">Glucose (mmol/L)</td><td align="left" rowspan="1" colspan="1">3.3(0.56–7.16)</td><td align="left" rowspan="1" colspan="1">3.2 (0.15–8.9)</td><td align="left" rowspan="1" colspan="1">0.51</td></tr></tbody></table></div><div id="largeobj_idm139768737210432" class="largeobj-link align_right" style="display: none;"><a target="object" href="/pmc/articles/PMC2951909/table/pone-0013223-t001/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="nt101"><sup></sup>Data are expressed in median (range).</div></div></div></div><div id="s3b" class="sec"><h3 id="s3btitle">Qualitative <sup>1</sup>H-NMR analysis and identification</h3><p id="__p25" class="p p-first">The <sup>1</sup>H-NMR signals of all common metabolites including amino-acids, organic acids, and carbohydrates were assigned according to previous publications. <a href="#pone.0013223-Wishart1" rid="pone.0013223-Wishart1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_675008746" role="button" aria-expanded="false" aria-haspopup="true">[17]</a>. Qualitative analysis of CSF by superimposition of spectra from ALS patients and controls did not reveal any differences in metabolite composition.We found particularly no trace of BMAA in the CSF of our ALS patients. Accurate visual comparison of the spectra was difficult because of dilution factor. An example of CSF spectra from a typical ALS patient and control are shown on <a href="/pmc/articles/PMC2951909/figure/pone-0013223-g001/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0013223-g001" rid-ob="ob-pone-0013223-g001" co-legend-rid="lgnd_pone-0013223-g001"><span>
<strong>figure 1</strong>
</span></a>.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="pone-0013223-g001" co-legend-rid="lgnd_pone-0013223-g001"><a href="/pmc/articles/PMC2951909/figure/pone-0013223-g001/" target="figure" rid-figpopup="pone-0013223-g001" rid-ob="ob-pone-0013223-g001"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139768753846384" class="figure"><a href="/pmc/articles/PMC2951909/figure/pone-0013223-g001/" target="figure" rid-figpopup="pone-0013223-g001" rid-ob="ob-pone-0013223-g001"></a><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2951909_pone.0013223.g001.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is pone.0013223.g001.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2951909/bin/pone.0013223.g001.jpg"></a></div><div id="largeobj_idm139768753846384" class="largeobj-link align_right" style="display: none;"><a target="object" href="/pmc/articles/PMC2951909/figure/pone-0013223-g001/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_pone-0013223-g001"><div><a class="figpopup" href="/pmc/articles/PMC2951909/figure/pone-0013223-g001/" target="figure" rid-figpopup="pone-0013223-g001" rid-ob="ob-pone-0013223-g001">Figure 1</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>CSF spectra by <sup>1</sup>H NMR from ALS patient (A) and non ALS patient (B).</strong></div></div></div></div><div id="s3c" class="sec"><h3 id="s3ctitle">Univariate data analysis</h3><p id="__p26" class="p p-first">We analysed 17 CSF metabolites in ALS and non ALS patients, defined as follows: amino-acids (alanine, glutamine, tyrosine), organic acids (citrate, acetate, α-hydroxybutyrate (AHBT)), ketone bodies (β-hydroxybutyrate (BHBT), acetone, acetoacetate), glucose, fructose, metabolites involved in glucose metabolism (pyruvate, lactate, creatinine and creatine, recently identified as markers of mitochondrial dysfunction <a href="#pone.0013223-Shaham1" rid="pone.0013223-Shaham1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_671900710" role="button" aria-expanded="false" aria-haspopup="true">[18]</a>, the anti-oxidant molecule ascorbate, and formate as well as ethanol.</p><p id="__p27" class="p">Results of quantitative analyses of metabolites in CSF from ALS patients and controls are presented in <a href="/pmc/articles/PMC2951909/table/pone-0013223-t002/" target="table" class="fig-table-link figpopup" rid-figpopup="pone-0013223-t002" rid-ob="ob-pone-0013223-t002" co-legend-rid=""><span>
<strong>table 2</strong>
</span></a>. We noted 3 metabolites for which mean CSF concentrations were significantly different between groups (p&lt;0.003). We found significantly lower concentrations of acetate in ALS patients than in controls (53 vs 104 µmol/L, p = 0.0002). There were higher concentrations of ascorbate and pyruvate in ALS patients compared to non ALS patients (p = 0.003 and p = 0.002, respectively). The lactate/pyruvate ratio, a marker of cytosolic oxido-reduction state was lower in ALS patients than in controls (56 vs 115, p = 0.0029). Acetone concentrations trended to be higher in ALS patients (p = 0.015). Box plots representing acetate, acetone, ascorbate, and pyruvate concentrations in the ALS and non ALS groups are shown in <a href="/pmc/articles/PMC2951909/figure/pone-0013223-g002/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0013223-g002" rid-ob="ob-pone-0013223-g002" co-legend-rid="lgnd_pone-0013223-g002"><span>
<strong>figure 2</strong>
</span></a>.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="pone-0013223-g002" co-legend-rid="lgnd_pone-0013223-g002"><a href="/pmc/articles/PMC2951909/figure/pone-0013223-g002/" target="figure" rid-figpopup="pone-0013223-g002" rid-ob="ob-pone-0013223-g002"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139768749934848" class="figure"><a href="/pmc/articles/PMC2951909/figure/pone-0013223-g002/" target="figure" rid-figpopup="pone-0013223-g002" rid-ob="ob-pone-0013223-g002"></a><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2951909_pone.0013223.g002.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is pone.0013223.g002.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2951909/bin/pone.0013223.g002.jpg"></a></div><div id="largeobj_idm139768749934848" class="largeobj-link align_right" style="display: none;"><a target="object" href="/pmc/articles/PMC2951909/figure/pone-0013223-g002/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_pone-0013223-g002"><div><a class="figpopup" href="/pmc/articles/PMC2951909/figure/pone-0013223-g002/" target="figure" rid-figpopup="pone-0013223-g002" rid-ob="ob-pone-0013223-g002">Figure 2</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Concentrations of different metabolites in ALS (n = 50) and non ALS patients (n = 44).</strong><p id="__p28">CSF concentrations of pyruvate (A), ascorbate (B), acetate (C) and acetone (D) are represented with median, upper and lower quartile, minimum and maximum data values.</p></div></div></div><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="pone-0013223-t002"><h3>Table 2</h3><!--caption a7--><div class="caption"><!--caption a8--><strong>CSF metabolite profiles in ALS and control subjects measured by <sup>1</sup>H NMR spectroscopy.</strong></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139768749930336" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><td align="left" rowspan="1" colspan="1">Metabolites (µmol/L)</td><td align="left" rowspan="1" colspan="1">ALS (n = 50)</td><td align="left" rowspan="1" colspan="1">Non ALS (n = 44)</td><td align="left" rowspan="1" colspan="1">p</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">AHBT</td><td align="left" rowspan="1" colspan="1">61 (0–137)</td><td align="left" rowspan="1" colspan="1">59 (0–177)</td><td align="left" rowspan="1" colspan="1">0.17</td></tr><tr><td align="left" rowspan="1" colspan="1">Ethanol</td><td align="left" rowspan="1" colspan="1">24 (0–170)</td><td align="left" rowspan="1" colspan="1">24 (0–460)</td><td align="left" rowspan="1" colspan="1">0.29</td></tr><tr><td align="left" rowspan="1" colspan="1">Alanine</td><td align="left" rowspan="1" colspan="1">56 (6–596)</td><td align="left" rowspan="1" colspan="1">61 (0–214)</td><td align="left" rowspan="1" colspan="1">0.74</td></tr><tr><td align="left" rowspan="1" colspan="1">Acetate</td><td align="left" rowspan="1" colspan="1">53 (9–389)</td><td align="left" rowspan="1" colspan="1">104 (2–366)</td><td align="left" rowspan="1" colspan="1">
<strong>0.0002</strong>
</td></tr><tr><td align="left" rowspan="1" colspan="1">BHBT</td><td align="left" rowspan="1" colspan="1">17 (4–85)</td><td align="left" rowspan="1" colspan="1">27 (0–134)</td><td align="left" rowspan="1" colspan="1">0.97</td></tr><tr><td align="left" rowspan="1" colspan="1">Lactate</td><td align="left" rowspan="1" colspan="1">2076 (444–3892)</td><td align="left" rowspan="1" colspan="1">2020 (94–5322)</td><td align="left" rowspan="1" colspan="1">0.81</td></tr><tr><td align="left" rowspan="1" colspan="1">Acetoacetate</td><td align="left" rowspan="1" colspan="1">9 (0–29)</td><td align="left" rowspan="1" colspan="1">8 (0–29)</td><td align="left" rowspan="1" colspan="1">0.89</td></tr><tr><td align="left" rowspan="1" colspan="1">Acetone</td><td align="left" rowspan="1" colspan="1">11 (0–59)</td><td align="left" rowspan="1" colspan="1">5 (0–23)</td><td align="left" rowspan="1" colspan="1">0.015</td></tr><tr><td align="left" rowspan="1" colspan="1">Glutamine</td><td align="left" rowspan="1" colspan="1">716 (139–1272)</td><td align="left" rowspan="1" colspan="1">785 (35–1296)</td><td align="left" rowspan="1" colspan="1">0.24</td></tr><tr><td align="left" rowspan="1" colspan="1">Pyruvate</td><td align="left" rowspan="1" colspan="1">68 (3–128)</td><td align="left" rowspan="1" colspan="1">17 (0–201)</td><td align="left" rowspan="1" colspan="1">
<strong>0.002</strong>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Citrate</td><td align="left" rowspan="1" colspan="1">283 (22–49)</td><td align="left" rowspan="1" colspan="1">285 (12–754)</td><td align="left" rowspan="1" colspan="1">0.51</td></tr><tr><td align="left" rowspan="1" colspan="1">Creatine/creatinine</td><td align="left" rowspan="1" colspan="1">155 (25–316)</td><td align="left" rowspan="1" colspan="1">160 (9–450)</td><td align="left" rowspan="1" colspan="1">0.65</td></tr><tr><td align="left" rowspan="1" colspan="1">Glucose</td><td align="left" rowspan="1" colspan="1">3240 (560–7166)</td><td align="left" rowspan="1" colspan="1">3174 (150–8928)</td><td align="left" rowspan="1" colspan="1">0.98</td></tr><tr><td align="left" rowspan="1" colspan="1">Fructose</td><td align="left" rowspan="1" colspan="1">428 (0–1224)</td><td align="left" rowspan="1" colspan="1">419 (0–967)</td><td align="left" rowspan="1" colspan="1">0.82</td></tr><tr><td align="left" rowspan="1" colspan="1">Ascorbate</td><td align="left" rowspan="1" colspan="1">25 (0–152)</td><td align="left" rowspan="1" colspan="1">0 (0–165)</td><td align="left" rowspan="1" colspan="1">
<strong>0.003</strong>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Tyrosine</td><td align="left" rowspan="1" colspan="1">12 (0–48)</td><td align="left" rowspan="1" colspan="1">8 (0–117)</td><td align="left" rowspan="1" colspan="1">0.35</td></tr><tr><td align="left" rowspan="1" colspan="1">Formate</td><td align="left" rowspan="1" colspan="1">28 (3–91)</td><td align="left" rowspan="1" colspan="1">30 (1–187)</td><td align="left" rowspan="1" colspan="1">0.35</td></tr></tbody></table></div><div id="largeobj_idm139768749930336" class="largeobj-link align_right" style="display: none;"><a target="object" href="/pmc/articles/PMC2951909/table/pone-0013223-t002/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="nt102"><sup></sup>Data are expressed in median and range. P value inferior to threshold after correction for multiple test (p = 0.003) are shown in bold.</div><div id="nt103"><sup></sup>AHBT: Alphahydroxybutyrate.</div><div id="nt104"><sup></sup>BHBT: Betahydroxybutyrate.</div></div></div></div><div id="s3d" class="sec sec-last"><h3 id="s3dtitle">PCA of the <sup>1</sup>H-NMR metabolite differences between ALS and non-ALS patients</h3><p id="__p32" class="p p-first">PCA analysis was applied to the NMR data using the 17 metabolites integrated in all patients. The resulting PCA score plot is shown in <a href="/pmc/articles/PMC2951909/figure/pone-0013223-g003/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0013223-g003" rid-ob="ob-pone-0013223-g003" co-legend-rid="lgnd_pone-0013223-g003"><span>
<strong>figure 3</strong>
</span></a>, with the two first PCs explaining 55.65% of the variation in the selected metabolites. The PCA scores plot for the quantitative NMR data showed separated clusters for ALS and non ALS patients. Each spectrum can be viewed as an observation in PCA space where the proximity of observations represents the similarity of the metabolic profiles of CSF samples. The PCA score plot shows the metabolites contributing to the separation of the two clusters and allows the identification of metabolites acting on this clustering. The ALS patients seemed to be characterized by high concentrations of pyruvate, ascorbate, and acetone whereas the non-ALS group seemed to be weighted by lower concentrations of these metabolites and by high concentrations of formate, acetate and β-hydroxybutyrate.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="pone-0013223-g003" co-legend-rid="lgnd_pone-0013223-g003"><a href="/pmc/articles/PMC2951909/figure/pone-0013223-g003/" target="figure" rid-figpopup="pone-0013223-g003" rid-ob="ob-pone-0013223-g003"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139768793023760" class="figure"><a href="/pmc/articles/PMC2951909/figure/pone-0013223-g003/" target="figure" rid-figpopup="pone-0013223-g003" rid-ob="ob-pone-0013223-g003"></a><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2951909_pone.0013223.g003.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is pone.0013223.g003.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2951909/bin/pone.0013223.g003.jpg"></a></div><div id="largeobj_idm139768793023760" class="largeobj-link align_right" style="display: none;"><a target="object" href="/pmc/articles/PMC2951909/figure/pone-0013223-g003/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_pone-0013223-g003"><div><a class="figpopup" href="/pmc/articles/PMC2951909/figure/pone-0013223-g003/" target="figure" rid-figpopup="pone-0013223-g003" rid-ob="ob-pone-0013223-g003">Figure 3</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Principal Component Analysis score plot for ALS (n = 50) and non ALS patients (n = 44).</strong></div></div></div><p id="__p33" class="p p-last">All metabolites were entered into the discriminant model. According to this panel of metabolites, we evaluated the clinical status of patients and identified that they were predicted in the correct group with a probability evaluated at 81.6%.</p></div></div><div id="s4" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="s4title">Discussion</h2><p id="__p34" class="p p-first">Metabolomic studies are a powerful approach to ascertaining metabolic signatures from a combination of small molecules in biological fluid and could lead to the identification of diagnostic or prognostic biomarkers. NMR spectroscopy is a non-invasive technique, needs little sample preparation and gives an overview of the principal metabolic pathways. To our knowledge, the present study is the first to address the potential use of <sup>1</sup>H NMR spectroscopy in analysing CSF from ALS patients.</p><p id="__p35">We compared CSF metabolic profiles between ALS and non-ALS patients. First, we conducted a qualitative analysis to measure any qualitative difference between groups. Among the 17 metabolites measured in our study, 13 were also analysed by Kumar et al. in serum samples of ALS patients <a href="#pone.0013223-Kumar1" rid="pone.0013223-Kumar1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_675008752" role="button" aria-expanded="false" aria-haspopup="true">[9]</a>, and we detected the same metabolites and in the same range as that reported in a previous study of human CSF metabolome <a href="#pone.0013223-Wishart1" rid="pone.0013223-Wishart1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_675008749" role="button" aria-expanded="false" aria-haspopup="true">[17]</a>. Importantly, glutamate could not be detected in CSF of patients and controls by NMR technique. Fiszmann in a recent study <a href="#pone.0013223-Fiszman1" rid="pone.0013223-Fiszman1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_671900713" role="button" aria-expanded="false" aria-haspopup="true">[19]</a> found a glutamate concentration around 0.6–0.9 µM in control CSF and 2.6–6.1 µM in ALS CSF. Even if there may be an increase of glutamate in ALS patients, the NMR methodology is not able to pick up such very low concentrations.</p><p id="__p36">Univariate analysis showed higher concentrations of CSF ascorbate in ALS patients. Two previous studies have compared concentrations of ascorbate between ALS patients and controls but results were contradictory <a href="#pone.0013223-Paraskevas1" rid="pone.0013223-Paraskevas1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_671900702" role="button" aria-expanded="false" aria-haspopup="true">[20]</a>–<a href="#pone.0013223-Ihara1" rid="pone.0013223-Ihara1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_671900708" role="button" aria-expanded="false" aria-haspopup="true">[21]</a>. The elevated levels of this anti-oxidant molecule are compatible with oxidative stress previously described in ALS and could also be linked to ascorbic acid release from astrocytes after glutamate stimulation <a href="#pone.0013223-Wilson1" rid="pone.0013223-Wilson1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_671900712" role="button" aria-expanded="false" aria-haspopup="true">[22]</a>, <a href="#pone.0013223-Castro1" rid="pone.0013223-Castro1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_671900698" role="button" aria-expanded="false" aria-haspopup="true">[23]</a>. Glutamate-mediated excitotoxicity is a recognized factor in the pathophysiology of ALS and could result in elevated levels of ascorbic acid. Ascorbic acid might, by itself, modulate neuronal metabolism through inhibition of glucose consumption during episodes of glutamatergic synaptic activity and by stimulating lactate uptake in neurons <a href="#pone.0013223-Castro1" rid="pone.0013223-Castro1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_671900694" role="button" aria-expanded="false" aria-haspopup="true">[23]</a>, <a href="#pone.0013223-Castro2" rid="pone.0013223-Castro2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_671900709" role="button" aria-expanded="false" aria-haspopup="true">[24]</a>, observations consistent with the lower lactate/pyruvate ratio seen in our ALS patients. These findings together with data previously published on metabolic modifications suggest a perturbation of brain glucose metabolism in patients with ALS <a href="#pone.0013223-Pradat1" rid="pone.0013223-Pradat1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_671900720" role="button" aria-expanded="false" aria-haspopup="true">[11]</a>.</p><p id="__p37">We also noted lower CSF concentrations of acetate and a trend toward higher CSF concentrations of acetone in ALS patients. We found no differences in other ketone bodies between ALS patients and controls, but did note high interindividual variability of these parameters. Kumar et al. described higher concentrations of ketone bodies (BHBT and acetone) and acetate in the serum of ALS patients <a href="#pone.0013223-Kumar1" rid="pone.0013223-Kumar1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_675008748" role="button" aria-expanded="false" aria-haspopup="true">[9]</a>. Based on the energetic metabolism in brain compared to the blood compartment, Kumar's results do not necessarily contradict our own. Hypermetabolism described in ALS patients may lead to increased energy requirements in muscle and brain <a href="#pone.0013223-Desport1" rid="pone.0013223-Desport1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_671900699" role="button" aria-expanded="false" aria-haspopup="true">[25]</a>, <a href="#pone.0013223-Kasarskis1" rid="pone.0013223-Kasarskis1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_671900700" role="button" aria-expanded="false" aria-haspopup="true">[26]</a>. Consequently, in addition to the usual energetic substrates (carbohydrates, lactate, fat), ketone bodies and acetate could also be used as a source of energy in the brains of ALS patients <a href="#pone.0013223-Deelchand1" rid="pone.0013223-Deelchand1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_671900721" role="button" aria-expanded="false" aria-haspopup="true">[27]</a>, <a href="#pone.0013223-Pawlosky1" rid="pone.0013223-Pawlosky1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_671900693" role="button" aria-expanded="false" aria-haspopup="true">[28]</a>. Thus the high levels of ketone bodies and acetate reported in serum could be due to the increased beta oxidation of fatty acids, related to higher energy needs <a href="#pone.0013223-Kumar1" rid="pone.0013223-Kumar1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_675008745" role="button" aria-expanded="false" aria-haspopup="true">[9]</a>, <a href="#pone.0013223-Dupuis1" rid="pone.0013223-Dupuis1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_671900715" role="button" aria-expanded="false" aria-haspopup="true">[29]</a>. Monocarboxylic acid transporters (MCT1) mediate the transport of ketone bodies and acetate from blood to brain through the Blood Brain Barrier (BBB) and their influx into the brain is largely determined by the amount of ketones and acetate present in the blood <a href="#pone.0013223-Deelchand1" rid="pone.0013223-Deelchand1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_671900697" role="button" aria-expanded="false" aria-haspopup="true">[27]</a>, <a href="#pone.0013223-Morris1" rid="pone.0013223-Morris1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_671900703" role="button" aria-expanded="false" aria-haspopup="true">[30]</a>. Thus, acetate, acetoacetate and β-hydroxybutyrate may be consumed by neurones and astrocytes to provide energy. However, metabolism of acetone is different than for the other ketones, perhaps explaining the still moderately higher level of acetone in ALS patients <a href="#pone.0013223-Kalapos1" rid="pone.0013223-Kalapos1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_671900711" role="button" aria-expanded="false" aria-haspopup="true">[31]</a>.</p><p id="__p38">Based on these data, we used two statistical approaches to assess diagnostic consistency in ALS.</p><p id="__p39">First, we performed the multivariate analysis PCA on the 17 metabolites detected by <sup>1</sup>H NMR spectroscopy to provide a metabolic signature for ALS. The scatter plot of PCA results derived from the NMR spectra discriminated between ALS and non-ALS populations. Of the metabolites responsible for the observed separation on the PCA score plot, we found the same discriminating metabolites as found using univariate analysis.</p><p id="__p40">A discriminant analysis was performed to predict the classification of ALS and non-ALS patients. The predictive power was superior to 80%, sufficient to consider this panel of metabolites useful in clinical practice. To our knowledge, Rozen et al. <a href="#pone.0013223-Rozen1" rid="pone.0013223-Rozen1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_671900696" role="button" aria-expanded="false" aria-haspopup="true">[8]</a> were the first and the only investigators to conduct a metabolomic study using a multivariate approach. They studied perturbations of the blood metabolome of 28 patients with motor neuron diseases (MND) and 30 healthy controls using high performance liquid chromatography. Of over 317 metabolites, they identified 50 that were elevated in MND patients and 70 that were decreased (p&lt;0.05). Similar to our study, they separated MND patients from controls using multivariate regression techniques.</p><p id="__p41">This study demonstrates that <sup>1</sup>H NMR spectroscopy combined with multivariate analysis can detect changes in the concentrations of some CSF metabolites in ALS, and highlights specific metabolic pathway perturbations. Moreover to our knowledge, this study is s the first to provide a diagnostic predictive power better than 80%. However, the composition of CSF may not be the direct consequence of metabolism in neurones and astrocytes, due in part to the role of other independent factors such as BBB transporters and release of metabolites from endothelial cells. Despite the invasiveness of lumbar puncture, the benefits of a correct diagnosis based on CSF component analysis may outweigh the risk of the puncture procedure. <a href="#pone.0013223-Lavi1" rid="pone.0013223-Lavi1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_671900714" role="button" aria-expanded="false" aria-haspopup="true">[32]</a> Future studies may reach improved sensitivity and specificity by comparing blood and CSF metabolites and discriminating the disturbances of metabolism in blood from brain.</p><p id="__p42">To our knowledge, this study is the first one reporting in CSF the use of <sup>1</sup>H NMR spectroscopy to explore metabolic pathways involved in the pathogenesis of ALS. Our data expand on previous studies and show promise that a biomarker panel could be developed for helping in the early diagnosis of ALS. Further studies with larger numbers of patients and controls, including other motor neuron diseases, will be crucial to validate this model and to assure its place in routine practice. It is also necessary to valid this panel of biomarkers in another cross-sectional study with a separate population, and of interest to perform a longitudinal study to determine predictive power of this model on disease progression.</p><p id="__p43" class="p p-last">A better understanding of heterogeneous genetic, biochemical and clinical features of ALS may help to define pathological profiles among ALS patients. This study focuses on the NMR profile, but we are aware that accuracy of early diagnosis of ALS will depend on combination of several approaches like imaging, electrophysiological and biological markers.</p></div><div id="idm139768749711088" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm139768749711088title">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="idm139768749710960"></p><p id="__p44" class="p p-first-last"><strong>Competing Interests: </strong>The authors have declared that no competing interests exist.</p><p></p><p class="fn sec" id="idm139768749709760"></p><p id="__p45" class="p p-first-last"><strong>Funding: </strong>The authors have no support or funding to report.</p><p></p></div></div><div id="idm139768753441840" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm139768753441840title">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="pone.0013223-Tandan1">1. <span class="element-citation">Tandan R, Bradley WG. Amyotrophic lateral sclerosis: Part 1. Clinical features, pathology, and ethical issues in management. <span><span class="ref-journal">Ann Neurol. </span>1985;<span class="ref-vol">18</span>:271–280.</span> [<a href="/pubmed/4051456" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Ann+Neurol&amp;title=Amyotrophic+lateral+sclerosis:+Part+1.+Clinical+features,+pathology,+and+ethical+issues+in+management.&amp;author=R+Tandan&amp;author=WG+Bradley&amp;volume=18&amp;publication_year=1985&amp;pages=271-280&amp;pmid=4051456&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0013223-Shaw1">2. <span class="element-citation">Shaw PJ. Molecular and cellular pathways of neurodegeneration in motor neurone disease. <span><span class="ref-journal">J Neurol Neurosurg Psychiatry. </span>2005;<span class="ref-vol">76</span>:1046–1057.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1739758/">PMC free article</a>]</span> [<a href="/pubmed/16024877" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Neurol+Neurosurg+Psychiatry&amp;title=Molecular+and+cellular+pathways+of+neurodegeneration+in+motor+neurone+disease.&amp;author=PJ+Shaw&amp;volume=76&amp;publication_year=2005&amp;pages=1046-1057&amp;pmid=16024877&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0013223-Kraemer1">3. <span class="element-citation">Kraemer M, Buerger M, Berlit P. Diagnostic problems and delay of diagnosis in amyotrophic lateral sclerosis. <span><span class="ref-journal">Clin Neurol Neurosurg. </span>2010;<span class="ref-vol">112</span>:103–105.</span> [<a href="/pubmed/19931253" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Neurol+Neurosurg&amp;title=Diagnostic+problems+and+delay+of+diagnosis+in+amyotrophic+lateral+sclerosis.&amp;author=M+Kraemer&amp;author=M+Buerger&amp;author=P+Berlit&amp;volume=112&amp;publication_year=2010&amp;pages=103-105&amp;pmid=19931253&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0013223-Mitchell1">4. <span class="element-citation">Mitchell RM, Freeman WM, Randazzo WT, Stephens HE, Beard JL, et al.  A CSF biomarker panel for identification of patients with amyotrophic lateral sclerosis. <span><span class="ref-journal">Neurology. </span>2009;<span class="ref-vol">72</span>:14–19.</span> [<a href="/pubmed/18987350" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Neurology&amp;title=A+CSF+biomarker+panel+for+identification+of+patients+with+amyotrophic+lateral+sclerosis.&amp;author=RM+Mitchell&amp;author=WM+Freeman&amp;author=WT+Randazzo&amp;author=HE+Stephens&amp;author=JL+Beard&amp;volume=72&amp;publication_year=2009&amp;pages=14-19&amp;pmid=18987350&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0013223-Sussmuth1">5. <span class="element-citation">Sussmuth SD, Brettschneider J, Ludolph AC, Tumani H. Biochemical markers in CSF of ALS patients. <span><span class="ref-journal">Curr Med Chem. </span>2008;<span class="ref-vol">15</span>:1788–1801.</span> [<a href="/pubmed/18691039" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Curr+Med+Chem&amp;title=Biochemical+markers+in+CSF+of+ALS+patients.&amp;author=SD+Sussmuth&amp;author=J+Brettschneider&amp;author=AC+Ludolph&amp;author=H+Tumani&amp;volume=15&amp;publication_year=2008&amp;pages=1788-1801&amp;pmid=18691039&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0013223-Tumani1">6. <span class="element-citation">Tumani H, Teunissen C, Sussmuth S, Otto M, Ludolph AC, et al.  Cerebrospinal fluid biomarkers of neurodegeneration in chronic neurological diseases. <span><span class="ref-journal">Expert Rev Mol Diagn. </span>2008;<span class="ref-vol">8</span>:479–494.</span> [<a href="/pubmed/18598229" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Expert+Rev+Mol+Diagn&amp;title=Cerebrospinal+fluid+biomarkers+of+neurodegeneration+in+chronic+neurological+diseases.&amp;author=H+Tumani&amp;author=C+Teunissen&amp;author=S+Sussmuth&amp;author=M+Otto&amp;author=AC+Ludolph&amp;volume=8&amp;publication_year=2008&amp;pages=479-494&amp;pmid=18598229&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0013223-Quinones1">7. <span class="element-citation">Quinones MP, Kaddurah-Daouk R. Metabolomics tools for identifying biomarkers for neuropsychiatric diseases. <span><span class="ref-journal">Neurobiol Dis. </span>2009;<span class="ref-vol">35</span>:165–176.</span> [<a href="/pubmed/19303440" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Neurobiol+Dis&amp;title=Metabolomics+tools+for+identifying+biomarkers+for+neuropsychiatric+diseases.&amp;author=MP+Quinones&amp;author=R+Kaddurah-Daouk&amp;volume=35&amp;publication_year=2009&amp;pages=165-176&amp;pmid=19303440&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0013223-Rozen1">8. <span class="element-citation">Rozen S, Cudkowicz ME, Bogdanov M, Matson WR, Kristal BS, et al.  Metabolomic analysis and signatures in motor neuron disease. <span><span class="ref-journal">Metabolomics. </span>2005;<span class="ref-vol">1</span>:101–108.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2553219/">PMC free article</a>]</span> [<a href="/pubmed/18820733" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Metabolomics&amp;title=Metabolomic+analysis+and+signatures+in+motor+neuron+disease.&amp;author=S+Rozen&amp;author=ME+Cudkowicz&amp;author=M+Bogdanov&amp;author=WR+Matson&amp;author=BS+Kristal&amp;volume=1&amp;publication_year=2005&amp;pages=101-108&amp;pmid=18820733&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0013223-Kumar1">9. <span class="element-citation">Kumar A, Bala L, Kalita J, Misra UK, Singh RL, et al.  Metabolomic analysis of serum by (1) H NMR spectroscopy in amyotrophic lateral sclerosis. <span><span class="ref-journal">Clin Chim Acta </span>2010</span> [<a href="/pubmed/20096678" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Chim+Acta&amp;title=Metabolomic+analysis+of+serum+by+(1)+H+NMR+spectroscopy+in+amyotrophic+lateral+sclerosis.&amp;author=A+Kumar&amp;author=L+Bala&amp;author=J+Kalita&amp;author=UK+Misra&amp;author=RL+Singh&amp;publication_year=2010&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0013223-AlaKorpela1">10. <span class="element-citation">Ala-Korpela M. Potential role of body fluid 1H NMR metabonomics as a prognostic and diagnostic tool. <span><span class="ref-journal">Expert Rev Mol Diagn. </span>2007;<span class="ref-vol">7</span>:761–773.</span> [<a href="/pubmed/18020906" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Expert+Rev+Mol+Diagn&amp;title=Potential+role+of+body+fluid+1H+NMR+metabonomics+as+a+prognostic+and+diagnostic+tool.&amp;author=M+Ala-Korpela&amp;volume=7&amp;publication_year=2007&amp;pages=761-773&amp;pmid=18020906&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0013223-Pradat1">11. <span class="element-citation">Pradat PF, Dib M. Biomarkers in amyotrophic lateral sclerosis: facts and future horizons. <span><span class="ref-journal">Mol Diagn Ther. </span>2009;<span class="ref-vol">13</span>:115–125.</span> [<a href="/pubmed/19537846" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Diagn+Ther&amp;title=Biomarkers+in+amyotrophic+lateral+sclerosis:+facts+and+future+horizons.&amp;author=PF+Pradat&amp;author=M+Dib&amp;volume=13&amp;publication_year=2009&amp;pages=115-125&amp;pmid=19537846&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0013223-Brooks1">12. <span class="element-citation">Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. <span><span class="ref-journal">Amyotroph Lateral Scler Other Motor Neuron Disord. </span>2000;<span class="ref-vol">1</span>:293–299.</span> [<a href="/pubmed/11464847" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Amyotroph+Lateral+Scler+Other+Motor+Neuron+Disord&amp;title=El+Escorial+revisited:+revised+criteria+for+the+diagnosis+of+amyotrophic+lateral+sclerosis.&amp;author=BR+Brooks&amp;author=RG+Miller&amp;author=M+Swash&amp;author=TL+Munsat&amp;volume=1&amp;publication_year=2000&amp;pages=293-299&amp;pmid=11464847&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0013223-Wuolikainen1">13. <span class="element-citation">Wuolikainen A, Hedenstrom M, Moritz T, Marklund SL, Antti H, et al.  Optimization of procedures for collecting and storing of CSF for studying the metabolome in ALS. <span><span class="ref-journal">Amyotroph Lateral Scler. </span>2009;<span class="ref-vol">10</span>:229–236.</span> [<a href="/pubmed/19412814" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Amyotroph+Lateral+Scler&amp;title=Optimization+of+procedures+for+collecting+and+storing+of+CSF+for+studying+the+metabolome+in+ALS.&amp;author=A+Wuolikainen&amp;author=M+Hedenstrom&amp;author=T+Moritz&amp;author=SL+Marklund&amp;author=H+Antti&amp;volume=10&amp;publication_year=2009&amp;pages=229-236&amp;pmid=19412814&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0013223-Barantin1">14. <span class="element-citation">Barantin L, Le Pape A, Akoka S. A new method for absolute quantitation of MRS metabolites. <span><span class="ref-journal">Magn Reson Med. </span>1997;<span class="ref-vol">38</span>:179–182.</span> [<a href="/pubmed/9256094" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Magn+Reson+Med&amp;title=A+new+method+for+absolute+quantitation+of+MRS+metabolites.&amp;author=L+Barantin&amp;author=A+Le+Pape&amp;author=S+Akoka&amp;volume=38&amp;publication_year=1997&amp;pages=179-182&amp;pmid=9256094&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0013223-Maillet1">15. <span class="element-citation">Maillet S, Vion-Dury J, Confort-Gouny S, Nicoli F, Lutz NW, et al.  Experimental protocol for clinical analysis of cerebrospinal fluid by high resolution proton magnetic resonance spectroscopy. <span><span class="ref-journal">Brain Res Brain Res Protoc. </span>1998;<span class="ref-vol">3</span>:123–134.</span> [<a href="/pubmed/9813277" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Brain+Res+Brain+Res+Protoc&amp;title=Experimental+protocol+for+clinical+analysis+of+cerebrospinal+fluid+by+high+resolution+proton+magnetic+resonance+spectroscopy.&amp;author=S+Maillet&amp;author=J+Vion-Dury&amp;author=S+Confort-Gouny&amp;author=F+Nicoli&amp;author=NW+Lutz&amp;volume=3&amp;publication_year=1998&amp;pages=123-134&amp;pmid=9813277&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0013223-Spencer1">16. <span class="element-citation">Spencer PS. Guam ALS/parkinsonism-dementia: a long-latency neurotoxic disorder caused by “slow toxin(s)” in food? <span><span class="ref-journal">Can J Neurol Sci. </span>1987;<span class="ref-vol">14</span>:347–357.</span> [<a href="/pubmed/3315142" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Can+J+Neurol+Sci&amp;title=Guam+ALS/parkinsonism-dementia:+a+long-latency+neurotoxic+disorder+caused+by+“slow+toxin(s)”+in+food?&amp;author=PS+Spencer&amp;volume=14&amp;publication_year=1987&amp;pages=347-357&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0013223-Wishart1">17. <span class="element-citation">Wishart DS, Lewis MJ, Morrissey JA, Flegel MD, Jeroncic K, et al.  The human cerebrospinal fluid metabolome. <span><span class="ref-journal">J Chromatogr B Analyt Technol Biomed Life Sci. </span>2008;<span class="ref-vol">871</span>:164–173.</span> [<a href="/pubmed/18502700" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Chromatogr+B+Analyt+Technol+Biomed+Life+Sci&amp;title=The+human+cerebrospinal+fluid+metabolome.&amp;author=DS+Wishart&amp;author=MJ+Lewis&amp;author=JA+Morrissey&amp;author=MD+Flegel&amp;author=K+Jeroncic&amp;volume=871&amp;publication_year=2008&amp;pages=164-173&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0013223-Shaham1">18. <span class="element-citation">Shaham O, Slate NG, Goldberger O, Xu Q, Ramanathan A, et al.  A plasma signature of human mitochondrial disease revealed through metabolic profiling of spent media from cultured muscle cells. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2010;<span class="ref-vol">107</span>:1571–1575.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2824369/">PMC free article</a>]</span> [<a href="/pubmed/20080599" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+U+S+A&amp;title=A+plasma+signature+of+human+mitochondrial+disease+revealed+through+metabolic+profiling+of+spent+media+from+cultured+muscle+cells.&amp;author=O+Shaham&amp;author=NG+Slate&amp;author=O+Goldberger&amp;author=Q+Xu&amp;author=A+Ramanathan&amp;volume=107&amp;publication_year=2010&amp;pages=1571-1575&amp;pmid=20080599&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0013223-Fiszman1">19. <span class="element-citation">Fiszman ML, Ricart KC, Latini A, Rodriguez G, Sica RE. In vitro neurotoxic properties and excitatory aminoacids concentration in the cerebrospinal fluid of amyotrophic lateral sclerosis patients. Relationship with the degree of certainty of disease diagnoses. <span><span class="ref-journal">Acta Neurol Scand. </span>2010;<span class="ref-vol">121</span>:120–126.</span> [<a href="/pubmed/19804473" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Acta+Neurol+Scand&amp;title=In+vitro+neurotoxic+properties+and+excitatory+aminoacids+concentration+in+the+cerebrospinal+fluid+of+amyotrophic+lateral+sclerosis+patients.+Relationship+with+the+degree+of+certainty+of+disease+diagnoses.&amp;author=ML+Fiszman&amp;author=KC+Ricart&amp;author=A+Latini&amp;author=G+Rodriguez&amp;author=RE+Sica&amp;volume=121&amp;publication_year=2010&amp;pages=120-126&amp;pmid=19804473&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0013223-Paraskevas1">20. <span class="element-citation">Paraskevas GP, Kapaki E, Libitaki G, Zournas C, Segditsa I, et al.  Ascorbate in healthy subjects, amyotrophic lateral sclerosis and Alzheimer's disease. <span><span class="ref-journal">Acta Neurol Scand. </span>1997;<span class="ref-vol">96</span>:88–90.</span> [<a href="/pubmed/9272183" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Acta+Neurol+Scand&amp;title=Ascorbate+in+healthy+subjects,+amyotrophic+lateral+sclerosis+and+Alzheimer's+disease.&amp;author=GP+Paraskevas&amp;author=E+Kapaki&amp;author=G+Libitaki&amp;author=C+Zournas&amp;author=I+Segditsa&amp;volume=96&amp;publication_year=1997&amp;pages=88-90&amp;pmid=9272183&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0013223-Ihara1">21. <span class="element-citation">Ihara Y, Nobukuni K, Takata H, Hayabara T. Oxidative stress and metal content in blood and cerebrospinal fluid of amyotrophic lateral sclerosis patients with and without a Cu, Zn-superoxide dismutase mutation. <span><span class="ref-journal">Neurol Res. </span>2005;<span class="ref-vol">27</span>:105–108.</span> [<a href="/pubmed/15829169" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Neurol+Res&amp;title=Oxidative+stress+and+metal+content+in+blood+and+cerebrospinal+fluid+of+amyotrophic+lateral+sclerosis+patients+with+and+without+a+Cu,+Zn-superoxide+dismutase+mutation.&amp;author=Y+Ihara&amp;author=K+Nobukuni&amp;author=H+Takata&amp;author=T+Hayabara&amp;volume=27&amp;publication_year=2005&amp;pages=105-108&amp;pmid=15829169&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0013223-Wilson1">22. <span class="element-citation">Wilson JX, Peters CE, Sitar SM, Daoust P, Gelb AW. Glutamate stimulates ascorbate transport by astrocytes. <span><span class="ref-journal">Brain Res. </span>2000;<span class="ref-vol">858</span>:61–66.</span> [<a href="/pubmed/10700597" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Brain+Res&amp;title=Glutamate+stimulates+ascorbate+transport+by+astrocytes.&amp;author=JX+Wilson&amp;author=CE+Peters&amp;author=SM+Sitar&amp;author=P+Daoust&amp;author=AW+Gelb&amp;volume=858&amp;publication_year=2000&amp;pages=61-66&amp;pmid=10700597&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0013223-Castro1">23. <span class="element-citation">Castro MA, Pozo M, Cortes C, Garcia Mde L, Concha II, et al.  Intracellular ascorbic acid inhibits transport of glucose by neurons, but not by astrocytes. <span><span class="ref-journal">J Neurochem. </span>2007;<span class="ref-vol">102</span>:773–782.</span> [<a href="/pubmed/17630983" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Neurochem&amp;title=Intracellular+ascorbic+acid+inhibits+transport+of+glucose+by+neurons,+but+not+by+astrocytes.&amp;author=MA+Castro&amp;author=M+Pozo&amp;author=C+Cortes&amp;author=L+Garcia+Mde&amp;author=II+Concha&amp;volume=102&amp;publication_year=2007&amp;pages=773-782&amp;pmid=17630983&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0013223-Castro2">24. <span class="element-citation">Castro MA, Beltran FA, Brauchi S, Concha II. A metabolic switch in brain: glucose and lactate metabolism modulation by ascorbic acid. <span><span class="ref-journal">J Neurochem. </span>2009;<span class="ref-vol">110</span>:423–440.</span> [<a href="/pubmed/19457103" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Neurochem&amp;title=A+metabolic+switch+in+brain:+glucose+and+lactate+metabolism+modulation+by+ascorbic+acid.&amp;author=MA+Castro&amp;author=FA+Beltran&amp;author=S+Brauchi&amp;author=II+Concha&amp;volume=110&amp;publication_year=2009&amp;pages=423-440&amp;pmid=19457103&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0013223-Desport1">25. <span class="element-citation">Desport JC, Torny F, Lacoste M, Preux PM, Couratier P. Hypermetabolism in ALS: correlations with clinical and paraclinical parameters. <span><span class="ref-journal">Neurodegener Dis. </span>2005;<span class="ref-vol">2</span>:202–207.</span> [<a href="/pubmed/16909026" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Neurodegener+Dis&amp;title=Hypermetabolism+in+ALS:+correlations+with+clinical+and+paraclinical+parameters.&amp;author=JC+Desport&amp;author=F+Torny&amp;author=M+Lacoste&amp;author=PM+Preux&amp;author=P+Couratier&amp;volume=2&amp;publication_year=2005&amp;pages=202-207&amp;pmid=16909026&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0013223-Kasarskis1">26. <span class="element-citation">Kasarskis EJ, Berryman S, Vanderleest JG, Schneider AR, McClain CJ. Nutritional status of patients with amyotrophic lateral sclerosis: relation to the proximity of death. <span><span class="ref-journal">Am J Clin Nutr. </span>1996;<span class="ref-vol">63</span>:130–137.</span> [<a href="/pubmed/8604660" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Clin+Nutr&amp;title=Nutritional+status+of+patients+with+amyotrophic+lateral+sclerosis:+relation+to+the+proximity+of+death.&amp;author=EJ+Kasarskis&amp;author=S+Berryman&amp;author=JG+Vanderleest&amp;author=AR+Schneider&amp;author=CJ+McClain&amp;volume=63&amp;publication_year=1996&amp;pages=130-137&amp;pmid=8604660&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0013223-Deelchand1">27. <span class="element-citation">Deelchand DK, Shestov AA, Koski DM, Ugurbil K, Henry PG. Acetate transport and utilization in the rat brain. <span><span class="ref-journal">J Neurochem. </span>2009;<span class="ref-vol">109</span>(Suppl 1):46–54.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2722917/">PMC free article</a>]</span> [<a href="/pubmed/19393008" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Neurochem&amp;title=Acetate+transport+and+utilization+in+the+rat+brain.&amp;author=DK+Deelchand&amp;author=AA+Shestov&amp;author=DM+Koski&amp;author=K+Ugurbil&amp;author=PG+Henry&amp;volume=109&amp;issue=Suppl+1&amp;publication_year=2009&amp;pages=46-54&amp;pmid=19393008&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0013223-Pawlosky1">28. <span class="element-citation">Pawlosky RJ, Kashiwaya Y, Srivastava S, King MT, Crutchfield C, et al.  Alterations in brain glucose utilization accompanying elevations in blood ethanol and acetate concentrations in the rat. <span><span class="ref-journal">Alcohol Clin Exp Res. </span>2010;<span class="ref-vol">34</span>:375–381.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2958045/">PMC free article</a>]</span> [<a href="/pubmed/19951290" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Alcohol+Clin+Exp+Res&amp;title=Alterations+in+brain+glucose+utilization+accompanying+elevations+in+blood+ethanol+and+acetate+concentrations+in+the+rat.&amp;author=RJ+Pawlosky&amp;author=Y+Kashiwaya&amp;author=S+Srivastava&amp;author=MT+King&amp;author=C+Crutchfield&amp;volume=34&amp;publication_year=2010&amp;pages=375-381&amp;pmid=19951290&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0013223-Dupuis1">29. <span class="element-citation">Dupuis L, Corcia P, Fergani A, Gonzalez De Aguilar JL, Bonnefont-Rousselot D, et al.  Dyslipidemia is a protective factor in amyotrophic lateral sclerosis. <span><span class="ref-journal">Neurology. </span>2008;<span class="ref-vol">70</span>:1004–1009.</span> [<a href="/pubmed/18199832" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Neurology&amp;title=Dyslipidemia+is+a+protective+factor+in+amyotrophic+lateral+sclerosis.&amp;author=L+Dupuis&amp;author=P+Corcia&amp;author=A+Fergani&amp;author=JL+Gonzalez+De+Aguilar&amp;author=D+Bonnefont-Rousselot&amp;volume=70&amp;publication_year=2008&amp;pages=1004-1009&amp;pmid=18199832&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0013223-Morris1">30. <span class="element-citation">Morris AA. Cerebral ketone body metabolism. <span><span class="ref-journal">J Inherit Metab Dis. </span>2005;<span class="ref-vol">28</span>:109–121.</span> [<a href="/pubmed/15877199" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Inherit+Metab+Dis&amp;title=Cerebral+ketone+body+metabolism.&amp;author=AA+Morris&amp;volume=28&amp;publication_year=2005&amp;pages=109-121&amp;pmid=15877199&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0013223-Kalapos1">31. <span class="element-citation">Kalapos MP. On the mammalian acetone metabolism: from chemistry to clinical implications. <span><span class="ref-journal">Biochim Biophys Acta. </span>2003;<span class="ref-vol">1621</span>:122–139.</span> [<a href="/pubmed/12726989" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biochim+Biophys+Acta&amp;title=On+the+mammalian+acetone+metabolism:+from+chemistry+to+clinical+implications.&amp;author=MP+Kalapos&amp;volume=1621&amp;publication_year=2003&amp;pages=122-139&amp;pmid=12726989&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0013223-Lavi1">32. <span class="element-citation">Lavi R, Rowe JM, Avivi I. Lumbar puncture: it is time to change the needle. <span><span class="ref-journal">Eur Neurol. </span>2010;<span class="ref-vol">64</span>:108–113.</span> [<a href="/pubmed/20628255" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur+Neurol&amp;title=Lumbar+puncture:+it+is+time+to+change+the+needle.&amp;author=R+Lavi&amp;author=JM+Rowe&amp;author=I+Avivi&amp;volume=64&amp;publication_year=2010&amp;pages=108-113&amp;pmid=20628255&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div></div></div><div style="display: none; width: 200px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbilinksmenu"><ul id="ui-ncbiinpagenav-2" style=""><li><a href="#idm139768753978592title">Abstract</a></li><li><a href="#s1title">Introduction</a></li><li><a href="#s2title">Methods</a></li><li><a href="#s3title">Results</a></li><li><a href="#s4title">Discussion</a></li><li><a href="#idm139768749711088title">Footnotes</a></li><li><a href="#idm139768753441840title">References</a></li></ul></div></div><!--post-content--><div class="courtesy-note whole_rhythm small"><hr>Articles from <span class="acknowledgment-journal-title">PLoS ONE</span> are provided here courtesy of <strong>Public Library of Science</strong></div></div>
            
            
        
            
        </div>
        <!-- Book content -->
    </div>
    
    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            
        </div>
        
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="/pmc/articles/PMC2951909/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="/pmc/articles/PMC2951909/epub/">ePub (beta)</a></li> | <li><a href="/pmc/articles/PMC2951909/pdf/pone.0013223.pdf">PDF (399K)</a></li> | <li><a href="#" data-citationid="PMC2951909" class="citationexporter ctxp" role="button" aria-expanded="false" aria-haspopup="true">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2951909%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626" alt="Share on Facebook">
                             Facebook
                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2951909%2F&amp;text=%0A1H-NMR-Based%20Metabolomic%20Profiling%20of%20CSF%20in%20Early%20Amyotrophic%20Lateral%20Sclerosis" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627" alt="Share on Twitter">
                             Twitter
                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2951909%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628" alt="Share on Google Plus">
                             Google+
                        </a></li></ul></div>
        
        <div id="ajax-portlets" data-pmid="20949041" data-aiid="2951909" data-aid="2951909" data-iid="190416" data-domainid="440" data-domain="plosone" data-accid="PMC2951909" data-md5="3207c41de9d75e8badea6a55c879177a">

<div>














</div>   
    </div>
                
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script>
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>



<div id="body-link-poppers"><div id="body-link-popper-pone.0013223-Tandan1" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Amyotrophic lateral sclerosis: Part 1. Clinical features, pathology, and ethical issues in management.<div class="authors">Tandan R, Bradley WG</div><div class="citation">Ann Neurol. 1985 Sep; 18(3):271-80.</div><p>[<a href="/pubmed/4051456/" ref="reftype=pubmed&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0013223-Tandan1">Ref list</a>]</p></div><div id="body-link-popper-pone.0013223-Shaw1" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true"><span class="invert">Review</span> Molecular and cellular pathways of neurodegeneration in motor neurone disease.<div class="authors">Shaw PJ</div><div class="citation">J Neurol Neurosurg Psychiatry. 2005 Aug; 76(8):1046-57.</div><p>[<a href="/pubmed/16024877/" ref="reftype=pubmed&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0013223-Shaw1">Ref list</a>]</p></div><div id="body-link-popper-pone.0013223-Kraemer1" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Diagnostic problems and delay of diagnosis in amyotrophic lateral sclerosis.<div class="authors">Kraemer M, Buerger M, Berlit P</div><div class="citation">Clin Neurol Neurosurg. 2010 Feb; 112(2):103-5.</div><p>[<a href="/pubmed/19931253/" ref="reftype=pubmed&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0013223-Kraemer1">Ref list</a>]</p></div><div id="body-link-popper-pone.0013223-Mitchell1" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">A CSF biomarker panel for identification of patients with amyotrophic lateral sclerosis.<div class="authors">Mitchell RM, Freeman WM, Randazzo WT, Stephens HE, Beard JL, Simmons Z, Connor JR</div><div class="citation">Neurology. 2009 Jan 6; 72(1):14-9.</div><p>[<a href="/pubmed/18987350/" ref="reftype=pubmed&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0013223-Mitchell1">Ref list</a>]</p></div><div id="body-link-popper-pone.0013223-Sussmuth1" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true"><span class="invert">Review</span> Biochemical markers in CSF of ALS patients.<div class="authors">Süssmuth SD, Brettschneider J, Ludolph AC, Tumani H</div><div class="citation">Curr Med Chem. 2008; 15(18):1788-801.</div><p>[<a href="/pubmed/18691039/" ref="reftype=pubmed&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0013223-Sussmuth1">Ref list</a>]</p></div><div id="body-link-popper-pone.0013223-Tumani1" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true"><span class="invert">Review</span> Cerebrospinal fluid biomarkers of neurodegeneration in chronic neurological diseases.<div class="authors">Tumani H, Teunissen C, Süssmuth S, Otto M, Ludolph AC, Brettschneider J</div><div class="citation">Expert Rev Mol Diagn. 2008 Jul; 8(4):479-94.</div><p>[<a href="/pubmed/18598229/" ref="reftype=pubmed&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0013223-Tumani1">Ref list</a>]</p></div><div id="body-link-popper-pone.0013223-Quinones1" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true"><span class="invert">Review</span> Metabolomics tools for identifying biomarkers for neuropsychiatric diseases.<div class="authors">Quinones MP, Kaddurah-Daouk R</div><div class="citation">Neurobiol Dis. 2009 Aug; 35(2):165-76.</div><p>[<a href="/pubmed/19303440/" ref="reftype=pubmed&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0013223-Quinones1">Ref list</a>]</p></div><div id="body-link-popper-pone.0013223-Rozen1" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Metabolomic analysis and signatures in motor neuron disease.<div class="authors">Rozen S, Cudkowicz ME, Bogdanov M, Matson WR, Kristal BS, Beecher C, Harrison S, Vouros P, Flarakos J, Vigneau-Callahan K, Matson TD, Newhall KM, Beal MF, Brown RH Jr, Kaddurah-Daouk R</div><div class="citation">Metabolomics. 2005; 1(2):101-108.</div><p>[<a href="/pubmed/18820733/" ref="reftype=pubmed&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0013223-Rozen1">Ref list</a>]</p></div><div id="body-link-popper-pone.0013223-Kumar1" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Metabolomic analysis of serum by (1) H NMR spectroscopy in amyotrophic lateral sclerosis.<div class="authors">Kumar A, Bala L, Kalita J, Misra UK, Singh RL, Khetrapal CL, Babu GN</div><div class="citation">Clin Chim Acta. 2010 Apr 2; 411(7-8):563-7.</div><p>[<a href="/pubmed/20096678/" ref="reftype=pubmed&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0013223-Kumar1">Ref list</a>]</p></div><div id="body-link-popper-pone.0013223-AlaKorpela1" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true"><span class="invert">Review</span> Potential role of body fluid 1H NMR metabonomics as a prognostic and diagnostic tool.<div class="authors">Ala-Korpela M</div><div class="citation">Expert Rev Mol Diagn. 2007 Nov; 7(6):761-73.</div><p>[<a href="/pubmed/18020906/" ref="reftype=pubmed&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0013223-AlaKorpela1">Ref list</a>]</p></div><div id="body-link-popper-pone.0013223-Pradat1" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true"><span class="invert">Review</span> Biomarkers in amyotrophic lateral sclerosis: facts and future horizons.<div class="authors">Pradat PF, Dib M</div><div class="citation">Mol Diagn Ther. 2009; 13(2):115-25.</div><p>[<a href="/pubmed/19537846/" ref="reftype=pubmed&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0013223-Pradat1">Ref list</a>]</p></div><div id="body-link-popper-pone.0013223-Brooks1" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true"><span class="invert">Review</span> El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis.<div class="authors">Brooks BR, Miller RG, Swash M, Munsat TL, World Federation of Neurology Research Group on Motor Neuron Diseases.</div><div class="citation">Amyotroph Lateral Scler Other Motor Neuron Disord. 2000 Dec; 1(5):293-9.</div><p>[<a href="/pubmed/11464847/" ref="reftype=pubmed&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0013223-Brooks1">Ref list</a>]</p></div><div id="body-link-popper-pone.0013223-Wuolikainen1" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Optimization of procedures for collecting and storing of CSF for studying the metabolome in ALS.<div class="authors">Wuolikainen A, Hedenström M, Moritz T, Marklund SL, Antti H, Andersen PM</div><div class="citation">Amyotroph Lateral Scler. 2009 Aug; 10(4):229-36.</div><p>[<a href="/pubmed/19412814/" ref="reftype=pubmed&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0013223-Wuolikainen1">Ref list</a>]</p></div><div id="body-link-popper-pone.0013223-Barantin1" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">A new method for absolute quantitation of MRS metabolites.<div class="authors">Barantin L, Le Pape A, Akoka S</div><div class="citation">Magn Reson Med. 1997 Aug; 38(2):179-82.</div><p>[<a href="/pubmed/9256094/" ref="reftype=pubmed&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0013223-Barantin1">Ref list</a>]</p></div><div id="body-link-popper-pone.0013223-Maillet1" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Experimental protocol for clinical analysis of cerebrospinal fluid by high resolution proton magnetic resonance spectroscopy.<div class="authors">Maillet S, Vion-Dury J, Confort-Gouny S, Nicoli F, Lutz NW, Viout P, Cozzone PJ</div><div class="citation">Brain Res Brain Res Protoc. 1998 Nov; 3(2):123-34.</div><p>[<a href="/pubmed/9813277/" ref="reftype=pubmed&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0013223-Maillet1">Ref list</a>]</p></div><div id="body-link-popper-pone.0013223-Spencer1" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true"><span class="invert">Review</span> Guam ALS/parkinsonism-dementia: a long-latency neurotoxic disorder caused by "slow toxin(s)" in food?<div class="authors">Spencer PS</div><div class="citation">Can J Neurol Sci. 1987 Aug; 14(3 Suppl):347-57.</div><p>[<a href="/pubmed/3315142/" ref="reftype=pubmed&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0013223-Spencer1">Ref list</a>]</p></div><div id="body-link-popper-pone.0013223-Wishart1" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">The human cerebrospinal fluid metabolome.<div class="authors">Wishart DS, Lewis MJ, Morrissey JA, Flegel MD, Jeroncic K, Xiong Y, Cheng D, Eisner R, Gautam B, Tzur D, Sawhney S, Bamforth F, Greiner R, Li L</div><div class="citation">J Chromatogr B Analyt Technol Biomed Life Sci. 2008 Aug 15; 871(2):164-73.</div><p>[<a href="/pubmed/18502700/" ref="reftype=pubmed&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0013223-Wishart1">Ref list</a>]</p></div><div id="body-link-popper-pone.0013223-Shaham1" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">A plasma signature of human mitochondrial disease revealed through metabolic profiling of spent media from cultured muscle cells.<div class="authors">Shaham O, Slate NG, Goldberger O, Xu Q, Ramanathan A, Souza AL, Clish CB, Sims KB, Mootha VK</div><div class="citation">Proc Natl Acad Sci U S A. 2010 Jan 26; 107(4):1571-5.</div><p>[<a href="/pubmed/20080599/" ref="reftype=pubmed&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0013223-Shaham1">Ref list</a>]</p></div><div id="body-link-popper-pone.0013223-Fiszman1" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">In vitro neurotoxic properties and excitatory aminoacids concentration in the cerebrospinal fluid of amyotrophic lateral sclerosis patients. Relationship with the degree of certainty of disease diagnoses.<div class="authors">Fiszman ML, Ricart KC, Latini A, Rodríguez G, Sica RE</div><div class="citation">Acta Neurol Scand. 2010 Feb; 121(2):120-6.</div><p>[<a href="/pubmed/19804473/" ref="reftype=pubmed&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0013223-Fiszman1">Ref list</a>]</p></div><div id="body-link-popper-pone.0013223-Paraskevas1" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Ascorbate in healthy subjects, amyotrophic lateral sclerosis and Alzheimer's disease.<div class="authors">Paraskevas GP, Kapaki E, Libitaki G, Zournas C, Segditsa I, Papageorgiou C</div><div class="citation">Acta Neurol Scand. 1997 Aug; 96(2):88-90.</div><p>[<a href="/pubmed/9272183/" ref="reftype=pubmed&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0013223-Paraskevas1">Ref list</a>]</p></div><div id="body-link-popper-pone.0013223-Ihara1" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Oxidative stress and metal content in blood and cerebrospinal fluid of amyotrophic lateral sclerosis patients with and without a Cu, Zn-superoxide dismutase mutation.<div class="authors">Ihara Y, Nobukuni K, Takata H, Hayabara T</div><div class="citation">Neurol Res. 2005 Jan; 27(1):105-8.</div><p>[<a href="/pubmed/15829169/" ref="reftype=pubmed&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0013223-Ihara1">Ref list</a>]</p></div><div id="body-link-popper-pone.0013223-Wilson1" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Glutamate stimulates ascorbate transport by astrocytes.<div class="authors">Wilson JX, Peters CE, Sitar SM, Daoust P, Gelb AW</div><div class="citation">Brain Res. 2000 Mar 6; 858(1):61-6.</div><p>[<a href="/pubmed/10700597/" ref="reftype=pubmed&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0013223-Wilson1">Ref list</a>]</p></div><div id="body-link-popper-pone.0013223-Castro1" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Intracellular ascorbic acid inhibits transport of glucose by neurons, but not by astrocytes.<div class="authors">Castro MA, Pozo M, Cortés C, García Mde L, Concha II, Nualart F</div><div class="citation">J Neurochem. 2007 Aug; 102(3):773-82.</div><p>[<a href="/pubmed/17630983/" ref="reftype=pubmed&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0013223-Castro1">Ref list</a>]</p></div><div id="body-link-popper-pone.0013223-Castro2" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true"><span class="invert">Review</span> A metabolic switch in brain: glucose and lactate metabolism modulation by ascorbic acid.<div class="authors">Castro MA, Beltrán FA, Brauchi S, Concha II</div><div class="citation">J Neurochem. 2009 Jul; 110(2):423-40.</div><p>[<a href="/pubmed/19457103/" ref="reftype=pubmed&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0013223-Castro2">Ref list</a>]</p></div><div id="body-link-popper-pone.0013223-Desport1" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Hypermetabolism in ALS: correlations with clinical and paraclinical parameters.<div class="authors">Desport JC, Torny F, Lacoste M, Preux PM, Couratier P</div><div class="citation">Neurodegener Dis. 2005; 2(3-4):202-7.</div><p>[<a href="/pubmed/16909026/" ref="reftype=pubmed&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0013223-Desport1">Ref list</a>]</p></div><div id="body-link-popper-pone.0013223-Kasarskis1" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Nutritional status of patients with amyotrophic lateral sclerosis: relation to the proximity of death.<div class="authors">Kasarskis EJ, Berryman S, Vanderleest JG, Schneider AR, McClain CJ</div><div class="citation">Am J Clin Nutr. 1996 Jan; 63(1):130-7.</div><p>[<a href="/pubmed/8604660/" ref="reftype=pubmed&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0013223-Kasarskis1">Ref list</a>]</p></div><div id="body-link-popper-pone.0013223-Deelchand1" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Acetate transport and utilization in the rat brain.<div class="authors">Deelchand DK, Shestov AA, Koski DM, Uğurbil K, Henry PG</div><div class="citation">J Neurochem. 2009 May; 109 Suppl 1():46-54.</div><p>[<a href="/pubmed/19393008/" ref="reftype=pubmed&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0013223-Deelchand1">Ref list</a>]</p></div><div id="body-link-popper-pone.0013223-Pawlosky1" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Alterations in brain glucose utilization accompanying elevations in blood ethanol and acetate concentrations in the rat.<div class="authors">Pawlosky RJ, Kashiwaya Y, Srivastava S, King MT, Crutchfield C, Volkow N, Kunos G, Li TK, Veech RL</div><div class="citation">Alcohol Clin Exp Res. 2010 Feb; 34(2):375-81.</div><p>[<a href="/pubmed/19951290/" ref="reftype=pubmed&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0013223-Pawlosky1">Ref list</a>]</p></div><div id="body-link-popper-pone.0013223-Dupuis1" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Dyslipidemia is a protective factor in amyotrophic lateral sclerosis.<div class="authors">Dupuis L, Corcia P, Fergani A, Gonzalez De Aguilar JL, Bonnefont-Rousselot D, Bittar R, Seilhean D, Hauw JJ, Lacomblez L, Loeffler JP, Meininger V</div><div class="citation">Neurology. 2008 Mar 25; 70(13):1004-9.</div><p>[<a href="/pubmed/18199832/" ref="reftype=pubmed&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0013223-Dupuis1">Ref list</a>]</p></div><div id="body-link-popper-pone.0013223-Morris1" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true"><span class="invert">Review</span> Cerebral ketone body metabolism.<div class="authors">Morris AA</div><div class="citation">J Inherit Metab Dis. 2005; 28(2):109-21.</div><p>[<a href="/pubmed/15877199/" ref="reftype=pubmed&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0013223-Morris1">Ref list</a>]</p></div><div id="body-link-popper-pone.0013223-Kalapos1" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true"><span class="invert">Review</span> On the mammalian acetone metabolism: from chemistry to clinical implications.<div class="authors">Kalapos MP</div><div class="citation">Biochim Biophys Acta. 2003 May 2; 1621(2):122-39.</div><p>[<a href="/pubmed/12726989/" ref="reftype=pubmed&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0013223-Kalapos1">Ref list</a>]</p></div><div id="body-link-popper-pone.0013223-Lavi1" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true"><span class="invert">Review</span> Lumbar puncture: it is time to change the needle.<div class="authors">Lavi R, Rowe JM, Avivi I</div><div class="citation">Eur Neurol. 2010; 64(2):108-13.</div><p>[<a href="/pubmed/20628255/" ref="reftype=pubmed&amp;article-id=2951909&amp;issue-id=190416&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0013223-Lavi1">Ref list</a>]</p></div></div>
                        </div>
                        <div class="bottom">
                            
                            

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        <div class="ui-ncbiautocomplete-holder shadow ui-ncbiautocomplete-holder-clearfix" aria-live="assertive" style="display: none; top: 64px; left: 459px; width: 670px; z-index: 1001;"><ul class="ui-ncbiautocomplete-options" role="listbox" aria-activedescendant="term"></ul><div class="ui-ncbiautocomplete-actions shadow" style="display: block;"><a class="ui-ncbiautocomplete-link-pref" style="display: none;">Preferences</a><a href="#" class="ui-ncbiautocomplete-link-off ui-ncbiautocomplete-link-pref-right" style="display: block;">Turn off</a></div></div><div style="display: none; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic">External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.</div></div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript>&lt;img alt="statistics" src="/stat?jsdisabled=true&amp;amp;ncbi_db=pmc&amp;amp;ncbi_pdid=article&amp;amp;ncbi_acc=&amp;amp;ncbi_domain=plosone&amp;amp;ncbi_report=record&amp;amp;ncbi_type=fulltext&amp;amp;ncbi_objectid=&amp;amp;ncbi_pcid=/articles/PMC2951909/&amp;amp;ncbi_app=pmc" /&gt;</noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- 95B63906E70AD421_0000SID /projects/PMC/PMCViewer@4.46 ptpmc101 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"></script>
<div class="ui-dialog ui-widget ui-widget-content ui-corner-all ui-front" style="display: none;" tabindex="-1" role="dialog" aria-describedby="epubDialog" aria-labelledby="ui-id-1"><div class="ui-dialog-titlebar ui-widget-header ui-corner-all ui-helper-clearfix"><span id="ui-id-1" class="ui-dialog-title">Making articles easier to read in PMC</span><button type="button" class="ui-button ui-widget ui-state-default ui-corner-all ui-button-icon-only ui-dialog-titlebar-close" role="button" title="Close"><span class="ui-button-icon-primary ui-icon ui-icon-closethick"></span><span class="ui-button-text">Close</span></button></div><div id="epubDialog" style="display: block;" class="ui-dialog-content ui-widget-content">  <p>We are experimenting with display styles that make it easier to read articles     in PMC.     Our first effort uses eBook readers, which have several "ease of reading"     features already built in.</p>  <p>These PMC articles are best viewed in the <em>iBooks     reader</em>. You may notice problems with the display of certain parts of an article     in other eReaders.</p>  <div class="ui-dialog-buttonpane ui-widget-content ui-helper-clearfix"><button id="cancelEpub" class="ui-state-default ui-corner-all">Cancel</button><button id="downloadEpub" style="float: left" class="ui-state-default ui-corner-all">Download article</button></div>          </div></div></body></htm
